Sterile bodily-fluid collection devices and methods
The device addresses contamination in body fluid sampling by using a presample reservoir and flow metering mechanism to isolate and meter fluid volumes, improving test accuracy and reducing healthcare risks and costs.
Patent Information
- Application Number
- JP2024115518
- Authority / Receiving Office
- JP · JP
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2012-12-04
- Filing Date
- 2024-07-19
- Publication Date
- 2024-11-26
- Estimated Expiration
- 2033-12-04
AI Technical Summary
Existing methods for parenterally obtaining body fluid samples are prone to contamination from microorganisms present on the skin and other external contaminants, leading to false positive and false negative test results, which can result in incorrect diagnoses and unnecessary treatments, as well as increased healthcare costs and patient risks.
A device comprising a presample reservoir, flow diversion mechanism, and flow metering mechanism that isolates and meters body fluid volumes to reduce contamination, ensuring accurate sample collection and transfer to sterile sample reservoirs.
The device effectively reduces contamination from external microorganisms, enhancing the accuracy of body fluid testing and minimizing healthcare risks and costs associated with false results.
Smart Images

Figure 2024164005000001_ABST
Abstract
Description
[Technical field]
[0001] CROSS-REFERENCE TO RELATED APPLICATIONS
[1001] This application claims priority to and the benefit of U.S. Provisional Patent Application No. 61,733,199, filed December 4, 2012, entitled "Sterile Bodily-Fluid Collection Device and Methods," the disclosure of which is incorporated herein by reference in its entirety.
[0002]
[1002] FIELD OF THE DISCLOSURE
[0002] Embodiments described herein relate generally to parenteral procurement of bodily fluid samples, and more particularly to devices and methods for parenterally obtaining bodily fluid samples with reduced contamination from microorganisms or other contaminants external to the source of the bodily fluid, such as microorganisms present on the skin. [Background technology]
[0003]
[1003] Healthcare professionals routinely perform various types of microbiological tests on patients using parenterally obtained bodily fluids. In some cases, patient samples (e.g., bodily fluids) are tested for the presence of one or more potentially undesirable microorganisms, such as bacteria, fungi, or yeasts (e.g., Candida). Microbiological tests may involve culturing the patient sample in one or more sterile containers containing a medium that promotes microbial growth, real-time diagnostics, and / or molecular PCR-based techniques. Generally, if such microorganisms are present in the patient sample, they will multiply in the medium over time. After a variable period of time (e.g., hours to days), the growth of the organisms can be detected by automated continuous monitoring. Such automated monitoring can detect carbon dioxide produced by the growth of the organisms. The medium can then be tested for the presence of the microorganism. If the microorganism is present in the medium, it indicates the presence of the same microorganism in the patient sample, which in turn indicates the presence of the same microorganism in the bodily fluid of the patient from which the sample was obtained. Thus, if the culture medium is determined to be present, the patient may be prescribed one or more antibiotics or other treatments specifically designed to treat or otherwise rid the patient of the undesirable microorganisms.
[0004]
[1004] However, patient samples can become contaminated during acquisition and / or can be otherwise prone to false positive results. One way in which contamination of a patient sample can occur is through the transfer of microorganisms from the body surface (e.g., microorganisms present on the skin) that are dislodged during the insertion of the needle into the patient's body and then transferred to the medium with the patient sample. Body surface microorganisms and / or other undesirable external microorganisms can be dislodged directly or via dislodged tissue fragments, hair follicles, sweat glands, and other skin appendage structures. Another possible source of contamination comes from the person drawing the patient sample. For example, a physician, phlebotomist, nurse, etc. can transfer contaminants from their own body (e.g., fingers, arms, etc.) to the patient sample and / or to the equipment housing the patient sample. More specifically, the equipment and / or devices used during the patient sample acquisition process (e.g., patient to needle, needle / tube to sample container, etc.) often include multiple fluid interfaces, each of which can create a potential point of contamination. The use of such instruments and / or devices typically involves manual intervention to connect and / or fluidly couple the various interfaces. Because these interfaces are not pre-assembled and sterilized as a single fluidly coupled system, they can be introduced into the patient sample via the user (e.g., physician, phlebotomist, etc.) and / or other sources of contamination (e.g., ambient air, contaminants on surfaces of tables and counters in the patient room, microorganisms transferred from linens or clothing, etc.). In some cases, such contaminants can grow in the culture medium and ultimately result in a positive microbiological test result, thereby falsely indicating the presence of such microorganisms in the body.
[0005]
[1005] In some cases, false positive and / or false negative results may be due to the given volume of the patient sample. For example, overfilling of volume-sensitive blood culture bottles may lead to false positive results, as noted in the instructions and / or warning labels from the manufacturers of such culture bottles and associated automated continuous monitoring microbial detection systems. Meanwhile, as another example, insufficient volume of the patient sample in the medium may result in false negative results. For example, in a study conducted by Mayo Clinic entitled "Optimized Pathogen Detection with 30- Compared to 20-Milliliter Blood Culture Draws" published in the December 2011 issue of the Journal of Clinical Microbiology, a patient sample volume of 20 milliliters (mL) can detect the presence of approximately 80% of bacteremia present in the patient sample, a patient sample volume of 40 mL can detect approximately 88% of bacteremia, and a patient sample volume of 60 mL can detect approximately 99% of bacteremia.
[0006]
[1006] Such inaccurate results as a result of contamination, insufficient patient sample volume, etc., are problematic when attempting to diagnose or treat a suspected disease or health condition. For example, a false negative result from a microbiology test may result in a patient's disease being misdiagnosed and / or treatment being delayed, which may in some cases result in the patient's death. Conversely, a false positive result from a microbiology test may result in a patient being unnecessarily subjected to one or more antimicrobial therapies, which may cause serious adverse patient reactions, including, for example, death, as well as unnecessary burdens and expenses to the health care system due to extended patient hospital stays and / or other complications associated with incorrect treatment. Furthermore, the use of diagnostic imaging equipment resulting from these false positive results is also problematic from a patient safety standpoint, as the cost, as well as the unnecessary exposure to high concentrations of radiation associated with various imaging procedures (e.g., CT scans), have many known adverse effects on long-term patient health.
[0007]
[1007] Thus, there is a need for sterile, "all-in-one" bodily fluid collection devices and methods that reduce microbial contamination in bodily fluid test samples, for example, by minimizing exposure of the patient sample and / or fluid interface to surrounding non-sterile conditions and / or other external sources of contamination. Further, there is a need for such bodily fluid collection devices to include means for accurately metering, measuring, and / or otherwise evaluating the bodily fluid transferred from the patient to a sample reservoir or medium that can be visually, computed, or otherwise communicated to medical personnel obtaining the patient sample in substantially real-time (e.g., at the patient's bedside). Summary of the Invention
[0008]
[1008] Described herein are devices for parenterally obtaining a bodily fluid sample with reduced contamination from microorganisms external to the bodily fluid source, such as microorganisms present on the skin and / or other undesirable external contaminants. In some embodiments, an apparatus for obtaining a bodily fluid sample from a patient includes a pre-sample reservoir, a flow diverting mechanism, and a flow metering mechanism. The pre-sample reservoir is configured to receive a first volume of bodily fluid to be drawn from the patient. The flow diverting mechanism includes an inlet port, a first outlet port, and a second outlet port, defining a first fluid flow path and a second fluid flow path. The inlet port can be coupled to a lumen-defining device to receive the bodily fluid from the patient. The first outlet port and the second outlet port are configured to fluidly couple the pre-sample reservoir and the sample reservoir, respectively, to the flow diverting mechanism. The first fluid flow path is configured to place the first outlet port in fluid communication with the inlet port, and the second fluid flow path is configured to place the second outlet port in fluid communication with the inlet port. The flow metering mechanism is in fluid communication with the first fluid flow path and the second fluid flow path. The flow metering mechanism is configured to meter a flow of a first volume of bodily fluid through the first fluid flow path into the pre-sample reservoir and a flow of a second volume of bodily fluid through the second fluid flow path into the sample reservoir, and the flow metering mechanism is configured to display a volume indicator associated with the first volume and the second volume. [Brief description of the drawings]
[0009] [Figure 1] 1 is a schematic diagram of a bodily fluid collection device according to an embodiment. [Diagram 2] 1 is a perspective view of a bodily fluid collection device according to an embodiment. [Diagram 3] FIG. 3 is an exploded perspective view of the bodily fluid collection device of FIG. 2. [Figure 4] 3. FIG. 4 is a cross-sectional side view of a housing included in the bodily fluid collection device of FIG. 2 taken along line X1-X1 of FIG. [Diagram 5] 3. FIG. 4 is a cross-sectional view of a movable member included in the bodily fluid collection device of FIG. 2 taken along line X2-X2 of FIG. [Figure 6]3. A cross-sectional view of a flow controller included in the bodily fluid collection device of FIG. 2 taken along line X3-X3 of FIG. [Figure 7] 4 is a cross-sectional view of a flow controller included in the bodily fluid collection device of FIG. 2 taken along line X4-X4 of FIG. 3. [Figure 8] FIG. 3 is a top view of the bodily fluid collection device of FIG. 2 in a first configuration. [Figure 9] 9 is a cross-sectional view taken along line X5-X5 of FIG. 8 of the bodily fluid collection device of FIG. 2 in a first configuration. [Figure 10] FIG. 3 is a top view of the bodily fluid collection device of FIG. 2 in a second configuration. [Figure 11] 16 is a cross-sectional view of the bodily fluid collection device of FIG. 2 in a second configuration taken along line X6-X6 of FIG. 10. [Figure 12] 16 is a cross-sectional view of the bodily fluid collection device of FIG. 2 in a third configuration taken along line X6-X6 of FIG. 10. [Figure 13] 16 is a cross-sectional view of the bodily fluid collection device of FIG. 2 in a fourth configuration taken along line X6-X6 of FIG. 10. [Figure 14] 1 is a perspective view of a bodily fluid collection device according to an embodiment. [Figure 15] 15 is a side cross-sectional view of the bodily fluid collection device of FIG. 14 taken along line X7-X7. [Figure 16] 1 is a perspective view of a bodily fluid collection device according to an embodiment. [Figure 17] FIG. 17 is an exploded perspective view of a flow diverter mechanism included in the bodily fluid collection device of FIG. 16. [Figure 18] 17 is a cross-sectional side view of a distribution member included in the bodily fluid collection device of FIG. 16 taken along line X8-X8 of FIG. 16. [Figure 19] FIG. 17 is a top view of the bodily fluid collection device of FIG. 16 in a first configuration. [Figure 20] 19 is a cross-sectional view of the bodily fluid collection device of FIG. 16 in a first configuration taken along line X9-X9 of FIG. 19. [Figure 21] FIG. 17 is a top view of the bodily fluid collection device of FIG. 16 in a second configuration. [Figure 22] 20 is a cross-sectional view taken along line X10-X10 of FIG. 21 of the bodily fluid collection device of FIG. 16 in a second configuration. [Figure 23] 1 is a perspective view of a bodily fluid collection device according to an embodiment. [Figure 24] 24 is a cross-sectional view taken along line X11-X11 of a portion of the bodily fluid collection device of FIG. 23 in a first configuration. [Diagram 25] 24 is a cross-sectional view taken along line X11-X11 of the bodily fluid collection device of FIG. 23 in a second configuration. [Figure 26] 1 is a perspective view of a bodily fluid collection device according to an embodiment. [Figure 27] FIG. 27 is an exploded perspective view of a flow diverter mechanism included in the bodily fluid collection device of FIG. 26. [Figure 28] 28 is a cross-sectional view of a distribution member included in the bodily fluid collection device of FIG. 27 taken along line X13-X13 of FIG. 27. [Figure 29] 27. A cross-sectional view of a coupling member included in the bodily fluid collection device of FIG. 26 taken along line X14-X14 of FIG. [Diagram 30] 27 is a cross-sectional view of a dial included in the bodily fluid collection device of FIG. 26 taken along line X15-X15 of FIG. 27. [Diagram 31] 27 is a cross-sectional view of a valve included in the bodily fluid collection device of FIG. 26 taken along line X16-X16 of FIG. 27. [Diagram 32] 27 is a cross-sectional view of the bodily fluid collection device of FIG. 26 in a first configuration taken along line X12-X12. [Diagram 33] 27 is a cross-sectional view taken along line X12-X12 of the bodily fluid collection device of FIG. 26 in a second configuration. [Diagram 34] 1 is a perspective view of a bodily fluid collection device according to an embodiment. [Diagram 35] FIG. 35 is an exploded perspective view of a flow diverter mechanism included in the bodily fluid collection device of FIG. 34. [Diagram 36] 37 is a cross-sectional view taken along line X17-X17 of a distribution member included in the flow dividing mechanism of FIG. 35. [Figure 37] FIG. 35 is a top view of a portion of the bodily fluid collection device of FIG. 34 in a first configuration. [Figure 38] FIG. 38 is a cross-sectional view taken along line X18-X18 of the portion of the bodily fluid collection device of FIG. 37 in the first configuration. [Figure 39] FIG. 34 is a top view of the bodily fluid collection device of FIG. 33 in a second configuration. [Diagram 40] 39. A cross-sectional view of the bodily fluid collection device of FIG. 33 in a second configuration taken along line X19-X19 of FIG. [Diagram 41] FIG. 1 is a perspective view of a bodily fluid collection device in a first configuration according to an embodiment. [Diagram 42] FIG. 42 is an exploded perspective view of a portion of the bodily fluid collection device of FIG. 41. [Diagram 43] FIG. 42 is a cross-sectional view taken along line X20-X20 of the bodily fluid collection device of FIG. 41 in a first configuration. [Diagram 44] 42 is a cross-sectional view taken along line X20-X20 of the bodily fluid collection device of FIG. 41 in a second configuration. [Diagram 45] FIG. 42 is a cross-sectional view taken along line X20-X20 of the bodily fluid collection device of FIG. 41 in a third configuration. [Diagram 46] FIG. 1 is a perspective view of a bodily fluid collection device in a first configuration according to an embodiment. [Figure 47] FIG. 46 is an exploded perspective view of a portion of the bodily fluid collection device of FIG. 45. [Figure 48] 48 is a side cross-sectional view of a distribution member included in the bodily fluid collection device of FIG. 46 taken along line X21-X21 of FIG. 47. [Figure 49] 48 is a side cross-sectional view of a movable member included in the bodily fluid collection device of FIG. 46 taken along line X22-X22 of FIG. 47. [Figure 50] FIG. 47 is a top view of the bodily fluid collection device of FIG. 46 in a first configuration. [Figure 51] 50. FIG. 53 is a cross-sectional view of the bodily fluid collection device of FIG. 46 in a first configuration taken along line X23-X23 of FIG. 50. [Figure 52]FIG. 47 is a top view of the bodily fluid collection device of FIG. 46 in a second configuration. [Diagram 53] 52. A cross-sectional view of the bodily fluid collection device of FIG. 46 in a second configuration taken along line X24-X24 of FIG. 52. [Figure 54] 1 is a perspective view of a bodily fluid collection device according to an embodiment. [Figure 55] FIG. 55 is a top view of the bodily fluid collection device of FIG. 54. [Figure 56] 1 is a flow chart illustrating a method of obtaining a bodily fluid sample with reduced contamination using a collection device according to an embodiment. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
[0010]
[1063] Described herein are devices for parenterally obtaining a bodily fluid sample with reduced contamination from microorganisms external to the bodily fluid source, such as microorganisms present on the skin and / or other undesirable external contaminants. In some embodiments, an apparatus for obtaining a bodily fluid sample from a patient includes a pre-sample reservoir, a flow diverting mechanism, and a flow metering mechanism. The pre-sample reservoir is configured to receive a first volume of bodily fluid to be drawn from the patient. The flow diverting mechanism includes an inlet port, a first outlet port, and a second outlet port, defining a first fluid flow path and a second fluid flow path. The inlet port can be coupled to a lumen-defining device to receive the bodily fluid from the patient. The first outlet port and the second outlet port are configured to fluidly couple the pre-sample reservoir and the sample reservoir, respectively, to the flow diverting mechanism. The first fluid flow path is configured to place the first outlet port in fluid communication with the inlet port, and the second fluid flow path is configured to place the second outlet port in fluid communication with the inlet port. The flow metering mechanism is in fluid communication with the first fluid flow path and the second fluid flow path. The flow metering mechanism is configured to meter a flow of a first volume of bodily fluid through the first fluid flow path into the pre-sample reservoir and a flow of a second volume of bodily fluid through the second fluid flow path into the sample reservoir, and the flow metering mechanism is configured to display a volume indicator associated with the first volume and the second volume.
[0011]
[1064] In some embodiments, an apparatus for obtaining a bodily fluid sample from a patient includes a pre-sample reservoir, a flow diversion mechanism, a flow controller, and a movable member. The pre-sample reservoir is configured to receive a first volume of bodily fluid to be drawn from the patient. The flow diversion mechanism includes an inlet port, a first outlet port, and a second outlet port. The inlet port is coupleable to a lumen-defining device to receive the bodily fluid from the patient. The first outlet port fluidly couples the pre-sample reservoir to the flow diversion mechanism, and the second outlet port fluidly couples the sample reservoir to the flow diversion mechanism. The flow controller is at least partially disposed within the flow diversion mechanism, and is movable between a first configuration in which the flow controller defines at least a portion of a fluid flow path between the inlet port and the first outlet port, and a second configuration in which the flow controller defines at least a portion of a fluid flow path between the inlet port and the second outlet port. The movable member is movably coupled to the flow diverter mechanism and is movable through the second outlet port between a first configuration in which the sample reservoir is fluidly isolated from the fluid flow path between the inlet port and the second outlet port and a second configuration in which the sample reservoir is in fluid communication with the fluid flow path between the inlet port and the second outlet port, The sample reservoir is configured to receive a second volume of bodily fluid drawn from the patient when the flow controller is in the second configuration and the movable member is in the second configuration.
[0012]
[1065] In some embodiments, an apparatus for obtaining a bodily fluid sample from a patient includes a pre-sample reservoir, a flow diverter mechanism, and a flow controller. The pre-sample reservoir is configured to receive a first volume of bodily fluid drawn from the patient. The flow diverter mechanism includes a housing and a distribution member. The housing defines a first opening and a second opening in fluid communication with the pre-sample reservoir. The distribution member is at least partially disposed within the housing and defines a fluid flow path in fluid communication with the second opening. The distribution member includes a coupling portion in fluid communication with the flow path and configured to be physically and fluidly coupled to the sample reservoir. The flow controller includes an inlet port configured to be coupled to the lumen-defining device to receive the bodily fluid from the patient. The flow controller is rotatably coupled to the flow diverter mechanism and is movable between a first configuration in which the inlet port is in fluid communication with the first opening and a second configuration in which the inlet port is in fluid communication with the second opening.
[0013]
[1066] In some embodiments, a method of using a flow metering transfer device having a flow splitting mechanism including an inlet port configured to be selectively positioned in fluid communication with a pre-sample reservoir and a sample reservoir, and a flow metering mechanism configured to meter a flow of bodily fluid from a patient to the pre-sample reservoir and to the sample reservoir includes establishing fluid communication between the patient and the inlet port of the flow metering transfer device. Fluid communication is then established between the port and the pre-sample reservoir. A flow of bodily fluid transferred from the patient to the pre-sample reservoir is metered. The method includes verifying, via the flow metering mechanism of the flow metering transfer device, that a pre-sample volume of bodily fluid disposed in the pre-sample reservoir is a first pre-sample volume of bodily fluid. With the pre-sample volume disposed in the pre-sample reservoir, the pre-sample reservoir is fluidly isolated from the port to seal the pre-sample volume of bodily fluid in the pre-sample reservoir. With the pre-sample reservoir fluidly isolated, the method includes establishing fluid communication between the port and the sample reservoir. A flow of bodily fluid transferred from the patient to the sample reservoir is metered. The method includes verifying, via a flow metering mechanism of a flow metering transfer device, that a sample volume of the bodily fluid disposed in the sample reservoir is a first sample volume of the bodily fluid.
[0014]
[1067] In some embodiments, the device includes a flow diverter mechanism and a flow controller. The flow diverter mechanism can define an inlet port, a first outlet port, a second outlet port, and a third outlet port. The first outlet port is fluidly coupled to the pre-sample reservoir, the second outlet port is fluidly coupled to the first sample reservoir, the third outlet port is fluidly coupled to the second sample reservoir, etc. All of the fluid reservoirs can be fluidly isolated from one another. The flow controller includes various fluid channels, which can allow fluid movement in a specified direction and can be configured to be operably coupled to the flow diverter mechanism. In use, when the flow diverter mechanism is in a first configuration, the flow controller can allow a flow of bodily fluid to enter the pre-sample reservoir. The flow diverter mechanism can be moved to a second configuration, where the flow controller can allow a flow of bodily fluid to enter the first sample reservoir. Additionally, the flow diverter mechanism can then be moved to a third configuration, whereby the flow controller can allow a flow of bodily fluid to enter the second sample reservoir.
[0015]
[1068] In some embodiments, the bodily fluid collection device can be configured to selectively divert a first predetermined volume of bodily fluid to a pre-sample reservoir before allowing flow of the second volume of bodily fluid into the first sample reservoir and / or flow of the third volume of bodily fluid into the second sample reservoir. In this manner, the second and / or third volume of bodily fluid can be used for diagnostic or other testing, while the first volume of bodily fluid, which may contain microorganisms from the body surface or other microbial sources external to the patient from whom the sample is obtained, is isolated. In some embodiments, the bodily fluid collection device can include additional sample reservoirs (e.g., 3, 4, 5, 6 or more) depending on the analytical and / or testing protocols to be performed.
[0016]
[1069] In some embodiments, the bodily fluid collection device can include flow metering to ensure that an appropriate volume of bodily fluid is collected from the patient and / or transferred to a given pre-sample reservoir and / or sample reservoir. The bodily fluid collection device can be configured to automatically divert and / or control the fluid flow after a metered volume of bodily fluid is collected. For example, when a first metered pre-sample volume is collected, the diversion mechanism can be configured to divert the bodily fluid flow to a first sample reservoir, and then after a first metered sample volume is collected, the diversion mechanism can be configured to divert the bodily fluid flow to a second sample reservoir, etc. In some embodiments, the bodily fluid collection device can include a metered volume display, such as a liquid crystal display (LCD), to provide a user with a visual indication of how much bodily fluid has been collected in each given individual sample reservoir. In some embodiments, multiple displays can be provided to allow for customized pre-sample and / or sample volume collection.
[0017]
[1070] As used in this specification and the appended claims, the singular forms "a," "an," and "the" include plural referents unless the context clearly dictates otherwise. Thus, for example, the term "an element" is intended to mean a single element or a combination of elements, and "a material" is intended to mean one or more materials or combinations thereof.
[0018]
[1071] As used herein, "body fluid" may include any fluid obtained from within a patient's body, including, but not limited to, blood, cerebrospinal fluid, urine, bile, lymphatic fluid, saliva, synovial fluid, serous fluid, pleural fluid, amniotic fluid, etc., or any combination thereof.
[0019]
[1072] As used herein, the terms "first predetermined amount," "first amount," and "first volume" describe an amount of bodily fluid configured to be received or contained by a first reservoir or a pre-sample reservoir. Although the terms "first amount" and "first volume" do not explicitly describe a predetermined amount, it should be understood that the first amount is a first predetermined amount unless explicitly stated differently.
[0020]
[1073] The terms "second amount" and "second volume" as used herein describe an amount of bodily fluid configured to be received or contained by the second or sample reservoir. The second amount can be any suitable amount of bodily fluid and it need not be a predetermined amount. Conversely, if expressly stated as such, the second amount received and contained by the second or sample reservoir can be a second predetermined amount.
[0021]
[1074] The term "set" as used herein can refer to multiple features or a single feature that includes multiple parts. For example, when referring to a set of walls, the set of walls can be considered as one wall that includes separate parts, or the set of walls can be considered as multiple walls. Similarly, an integrally constructed article can include a set of walls. Such a set of walls can include, for example, multiple parts that are discontinuous with each other. It is also possible for a set of walls to be manufactured from multiple articles that are manufactured separately and then joined together (e.g., via welding, adhesive, or any suitable method).
[0022]
[1075] As used herein, the terms "proximal" and "distal" refer to directions toward and away from a user who places the device in contact with a patient. Thus, for example, the end of the device that first contacts the patient's body would be the distal end, and the opposite end of the device (e.g., the end of the device that is manipulated by the user) would be the proximal end of the device.
[0023]
[1076] As used herein, the terms "about," "approximately," and "substantially," when used in connection with a numerical value, are intended to mean that the value so defined is the nominally indicated value. In other words, the terms about, approximately, and substantially, when used in connection with a numerical value, generally include the indicated value plus or minus a given tolerance. For example, in some cases, a suitable tolerance may be ±10% of the indicated value, so that about 0.5 includes 0.45 and 0.55, about 10 includes 9-11, and about 1000 includes 900-1100. In other cases, a suitable tolerance may be plus or minus an acceptable percentage of the last significant figure of the indicated value. For example, a suitable tolerance may be ±10% of the last significant figure, so that about 10.1 includes 10.09 and 10.11, and about 25 includes 24.5 and 25.5. Such variations may result from manufacturing tolerances or other practical considerations (e.g., tolerances associated with measuring instruments, acceptable human error, etc.).
[0024]
[1077] When describing the relationship between a predetermined volume of bodily fluid and a collected volume of bodily fluid, it should be understood that those values include suitable tolerances, such as those described above. For example, when describing a collected volume of bodily fluid as substantially equal to a predetermined volume of bodily fluid, the collected volume and the predetermined volume are nominally equal within a suitable tolerance. In some cases, the tolerance can be determined by the intended use of the collected volume of bodily fluid. For example, in some cases, a blood culture assay can be about 99% accurate when the collected volume of blood is within 1.0% to 5.0% of the manufacturer's (or evidence-based best practice) recommended volume. By way of example, the manufacturer's recommended volume for an assay of a bodily fluid can be 10 milliliters (mL) per sample collection bottle (i.e., a total volume of 40 ml to 60 ml) ±5% when a total of four or six collection bottles are used, for about 99% confidence. Thus, a collection volume of 10.5 mL provides results with greater than about 99% confidence, and a collection volume of 11 mL provides results with less than about 99% confidence. In other cases, the suitable tolerance may be 0.1%, 0.5%, 1.0%, 2.0%, 3.0%, 4.0%, 5.0%, 6.0%, 7.0%, 8.0%, 9.0%, 10.0%, or any fractional value therebetween. In still other cases, the tolerance may be greater than 10.0%. Thus, any of the embodiments described herein may include and / or be used with any suitable flow measurement mechanism and / or device configured to meter the flow rate of bodily fluids and / or otherwise measure the volume of bodily fluids within suitable tolerances. Additionally, the flow metering mechanism and / or device may be positioned to minimize or eliminate tolerance buildup that may result from a combination of inaccurate measurements, human error, and the like.
[0025]
[1078] 1 is a schematic diagram of a portion of a bodily fluid collection device 100 according to an embodiment. Generally, bodily fluid collection device 100 (also referred to herein as a "fluid collection device" or "collection device") is configured to allow for the withdrawal of bodily fluid from a patient, where a first portion or amount of the withdrawn bodily fluid is diverted away from a second portion or volume and / or a third portion or volume of the withdrawn bodily fluid that is used as a biological sample, such as to be tested for medical diagnostic and / or therapeutic purposes. In other words, as described in more detail herein, collection device 100 is configured to transfer a first predetermined volume of bodily fluid to a pre-sample collection reservoir and a second and third (or in some embodiments, a fourth, fifth, etc.) volume of bodily fluid to one or more sample collection reservoirs (e.g., sample reservoirs) that are fluidly isolated from the pre-sample reservoir.
[0026]
[1079] The collection device 100 includes a flow splitter mechanism 120, a flow controller 140, a pre-sample reservoir 170, a first sample reservoir 180, and a second sample reservoir 190 different from the first sample reservoir 180. The flow splitter mechanism 120 includes an inlet port 121 and at least two outlet ports, such as a first outlet port 125 and a second outlet port 126, as shown in FIG. 1. In some embodiments, the flow splitter mechanism 120 can include a set of outlet ports equal to the total number of pre-sample and sample reservoirs. For example, if the collection device 100 has one pre-sample and four sample reservoirs, the flow splitter mechanism 120 can include five outlet ports. In some embodiments, the flow splitter mechanism 120 can be operably coupled to an actuator (not shown in FIG. 1) that can facilitate movement of the flow splitter mechanism 120 between multiple configurations. The inlet port 121 is configured to be fluidly coupled to a medical device defining a path X for withdrawing and / or transporting bodily fluid from a patient to the collection device 100. For example, the inlet port 121 may be fluidly coupled to a needle or other lumen-defining device (e.g., flexible sterile tubing). In this manner, the flow diverter mechanism 120 may receive bodily fluid from a patient via a needle or any other lumen-defining device.
[0027]
[1080] The first outlet port 125 of the flow diversion mechanism 120 can be fluidly coupled to the pre-sample reservoir 170. In some embodiments, the pre-sample reservoir 170 is integrally formed with the first outlet port 125 and / or a portion of the flow diversion mechanism 120. In other embodiments, the pre-sample reservoir 170 can be mechanically and / or fluidly coupled to the flow diversion mechanism 120 via adhesive, a resistance fit, mechanical fasteners, any number of mating recesses, a threaded connection, and / or any other suitable connection or combination thereof. Similarly, the pre-sample reservoir 170 can be physically (e.g., mechanically) coupled to the flow diversion mechanism 120 such that an interior volume defined by the pre-sample reservoir 170 is in fluid communication with the first outlet port 125 of the flow diversion mechanism 120. In yet other embodiments, the pre-sample reservoir 170 can be operably coupled to the first outlet port 125 of the flow diversion mechanism 120 via an intervening structure (not shown in FIG. 1 ), such as flexible sterile tubing. More particularly, the intervening structure can define a lumen configured to place the pre-sample reservoir 170 in fluid communication with the first outlet port 125.
[0028]
[1081] Pre-sample reservoir 170 is configured to receive and contain a first predetermined volume of bodily fluid. In some embodiments, pre-sample reservoir 170 is configured to contain the first volume of bodily fluid in fluid isolation from a second and / or third volume of bodily fluid (which may be the same as or different from the first volume of bodily fluid) that is subsequently drawn from the patient. Pre-sample reservoir 170 may be any suitable reservoir for containing bodily fluid, such as the pre-sample reservoirs described in detail in U.S. Pat. No. 8,197,420, entitled "Systems and Methods for Parenterally Procuring Bodily-Fluid Samples with Reduced Contamination," which is incorporated herein by reference in its entirety.
[0029]
[1082] In some embodiments, the second outlet port 126 of the flow diversion mechanism 120 is configured to be fluidly coupled to a lumen-defining device that can be coupled to the first sample reservoir 180 and the second sample reservoir 190. Optionally, in other embodiments, the second outlet port 126 of the flow diversion mechanism 120 can be coupled to the first sample reservoir 180, and the flow diversion mechanism 120 can have a third outlet port (not shown) coupled to the second sample reservoir 190. In some embodiments, the first sample reservoir 180 can be integrally formed with the second outlet port 126 and / or a portion of the flow diversion mechanism 120. In other embodiments, the first sample reservoir 180 can be mechanically coupled to the second outlet port 126 or operably coupled to the second outlet port 126 via an intervening structure such as described above with respect to the pre-sample reservoir 170. The first sample reservoir 180 is configured to receive and contain a second volume of bodily fluid. For example, the second volume of bodily fluid can be an amount drawn from the patient following the drawing of the first pre-sample volume. In some embodiments, the first sample reservoir 180 is configured to contain the second volume of bodily fluid such that the second volume is fluidly isolated from the first volume of pre-sample bodily fluid.
[0030]
[1083] The first sample reservoir 180 and the second sample reservoir 190 can be any suitable sterile reservoir for containing bodily fluid, including, for example, a sample reservoir such as those described in the '420 patent incorporated by reference above. In some embodiments, the second volume can be any suitable volume of bodily fluid and it need not be a predetermined volume. In other embodiments, the transfer of bodily fluid to the first sample reservoir 180 and / or the second sample reservoir 190 can be metered, etc., such that the second volume is a second predetermined volume.
[0031]
[1084] The second sample reservoir 190 may be any suitable sample reservoir. In some embodiments, the second sample reservoir 190 may be substantially similar to the first sample reservoir 180 described above. The second sample reservoir 190 may be fluidly coupled to the second outlet port 126 as described above. The fluid coupling of the second outlet port 126 to the second sample reservoir 190 may be substantially similar to the fluid coupling of the second outlet port 126 to the first sample reservoir 180 as described in detail above. Thus, such portions will not be described in further detail herein and should be considered to be substantially similar unless expressly described differently. Additionally, additional outlet ports and sample reservoirs of the flow splitter mechanism 120 (not shown in FIG. 1 ) may be substantially similar to the second outlet port 126 and the first sample reservoir 180.
[0032]
[1085] In some embodiments, the pre-sample reservoir 170, the first sample reservoir 180, and the second sample reservoir 190 may be similarly coupled (or formed together) with the flow diversion mechanism 120. In other embodiments, the pre-sample reservoir 170, the first sample reservoir 180, and the second sample reservoir 190 need not be similarly coupled to the flow diversion mechanism 120. For example, in some embodiments, the pre-sample reservoir 170 may be integrally formed with the flow diversion mechanism 120 (e.g., the first outlet port 124), and the first sample reservoir 180 and / or the second sample reservoir 190 may be operably coupled to the flow diversion mechanism 120 (e.g., the second outlet port 126) via an intervening structure, such as flexible sterile tubing, or any combination thereof.
[0033]
[1086] In some embodiments, the collection device 100 may further include an actuator (not shown in FIG. 1 ) and a flow controller 140 defining a first fluid flow path 142, a second fluid flow path 144, and optionally additional fluid flow paths (not shown in FIG. 1 ). In some embodiments, the actuator may be included in or otherwise operatively coupled to the flow diverter mechanism 120. In this manner, the actuator may be configured to control fluid movement within the flow controller 140 (e.g., between different configurations). For example, the actuator may be movable between a first position corresponding to a first configuration of the flow controller 140, a second position different from the first position corresponding to a second configuration of the flow controller 140, and so on. In some embodiments, the actuator may be configured to move in a single direction. For example, the actuator may be moved from its first position to its second position, but may not be moved from its second position back to its first position. Similarly, the actuator may be moved from its second position to a third position, but may not be moved from its third position back to its second position. In this manner, flow controller 140 is prevented from moving to its second or third form before its first form, so that a first amount of bodily fluid is directed to pre-sample reservoir 170 and not to sample reservoirs 180 and / or 190 designed to contain a second and / or third volume of extracted fluid to be used as a biological sample, such as for testing for medical diagnostic and / or therapeutic purposes.
[0034]
[1087] The flow controller 140 is configured such that when in the first configuration, the first fluid flow path 142 fluidly couples the inlet port 121 to the first outlet port 125, and when in the second configuration, the second fluid flow path 144 fluidly couples the inlet port 121 to the second outlet port 126. In some embodiments, an actuator, as described above, may be configured to move the flow controller 140 in a translational motion between the first and second configurations, and optionally the third or fourth configurations. For example, in some embodiments, the flow controller 140 may be in the first configuration when in a distal position relative to the collection device 100. In such embodiments, the actuator may be actuated to move the flow controller 140 proximally to a proximal position relative to the collection device 100, thereby placing the flow controller 130 in the second configuration. In other embodiments, the actuator may be actuated to move the flow controller 140 in a rotational motion between the first and second configurations, or optionally the third or fourth configurations.
[0035]
[1088] Thus, when flow controller 140 is in the first configuration, second outlet port 126 (and optionally an additional outlet port coupled to a sample reservoir) is fluidically isolated from inlet port 121. Similarly, when flow controller 140 is in the second configuration, first outlet port 125 is fluidically isolated from inlet port 121. Optionally, when flow controller 140 is in a third configuration (not shown in FIG. 1 ), first outlet port 125 and second outlet port 126 are fluidically isolated from inlet port 121. Thus, when flow controller 140 is in the first configuration, it can direct or divert a first amount of bodily fluid via first outlet port 125 to pre-sample fluid reservoir 170, and when flow controller 140 is in the second configuration, it can direct or divert a second amount of bodily fluid via second outlet port 126 to first sample fluid reservoir 180.
[0036]
[1089] In some embodiments, at least a portion of the actuator may be operably coupled to the pre-sample fluid reservoir 170. As such, the actuator (or at least a portion of the actuator) may be configured to cause or otherwise facilitate the creation of a vacuum in the "pre-sample" fluid reservoir 170, thereby initiating the flow of bodily fluid through the collection device 100 and into the pre-sample fluid reservoir 170 when the flow diverter mechanism 120 is in its first configuration. The actuator may include any suitable mechanism for driving the flow of bodily fluid into the collection device 100, such as, for example, a rotating disk, a plunger, a slide, a dial, a button, a handle, a lever, and / or any other suitable mechanism or combination thereof. Examples of suitable actuators are described in more detail herein with reference to specific embodiments.
[0037]
[1090] In some embodiments, the flow diversion mechanism 120 can be configured to require transport of a first amount of bodily fluid to the pre-sample fluid reservoir 170 before allowing a flow of a second amount of bodily fluid to be transported through the flow diversion mechanism 120 to the first sample fluid reservoir 180 and / or the second sample fluid reservoir 190. In this manner, the flow diversion mechanism 120 can be characterized as requiring compliance by a medical practitioner with collecting a first predetermined amount of bodily fluid (e.g., a pre-sample) before collecting a second and / or third amount of bodily fluid (e.g., a sample). Similarly, the flow diversion mechanism 120 can be configured to prevent a medical practitioner from collecting a second amount of bodily fluid, i.e., a sample, in the first sample fluid reservoir 180 without first diverting the first amount of bodily fluid, i.e., the pre-sample, to the pre-sample reservoir 170. In this manner, the medical practitioner is prevented from including (either intentionally or unintentionally) a first amount of bodily fluid that is more likely to contain surface microorganisms and / or other undesirable external contaminants in the bodily fluid sample used for analysis. In other embodiments, the fluid collection device 100 need not include a mandatory compliance feature or component.
[0038]
[1091] In some embodiments, the flow diversion mechanism 120 can have a fourth configuration (not shown in FIG. 1 ) that is different from the first, second, and third configurations. When in the fourth configuration, the flow diversion mechanism 120 can fluidly isolate the inlet port 121 from the first outlet port 125, the second outlet port 126, and optionally the third outlet port simultaneously. Thus, when the flow diversion mechanism 120 is in its fourth configuration, bodily fluid is prevented from flowing from the inlet port 121 to the pre-sample fluid reservoir 170, the first sample fluid reservoir 180, and the second sample fluid reservoir 190. In use, for example, the flow diverter mechanism 120 can be actuated (e.g., manually or automatically) to place the flow diverter mechanism 120 in a first configuration to allow bodily fluid to flow from the inlet port 121 to the pre-sample fluid reservoir 170, then moved to a second configuration to allow bodily fluid to flow from the inlet port 121 to the first sample fluid reservoir 180, and optionally moved to a third configuration to allow bodily fluid to flow from the inlet port 121 to the second sample fluid reservoir 190, and then moved to a fourth configuration to stop the flow of bodily fluid into and / or through the flow diverter mechanism 120. In this manner, the device is effectively "locked" and self-contained in the fourth configuration such that any residual bodily fluid within the device 100 is prevented from contaminating and / or otherwise exposing medical personnel and / or patients to potentially dangerous fluids. This optional safety feature can prevent possible exposure to bodily fluid samples that may be infected with pathogens such as HIV, Hepatitis C, etc.
[0039]
[1092] In some embodiments, one or more portions of the collection device 100 are disposed within a housing (not shown in FIG. 1). For example, in some embodiments, at least a portion of the flow diversion mechanism 120, the first pre-sample reservoir 170, and one or more of the sample reservoirs 180 and 190 may be disposed within the housing. In such embodiments, at least a portion of the flow diversion mechanism 120 is accessible through the housing such that a user can activate the flow controller 140 to control the flow of bodily fluid from a patient (e.g., a vein) to the collection device 100. Examples of suitable housings are described in more detail herein with reference to specific embodiments.
[0040]
[1093] In some embodiments, the collection device 100 can optionally include one or more flow metering devices capable of metering the flow of bodily fluid through the collection device. For example, the flow metering devices can be in fluid communication with the first fluid flow path 142 and / or the second fluid flow path 144 to meter the flow of bodily fluid therethrough. In other embodiments, the flow metering devices can be in fluid communication with and / or otherwise disposed at the first port 125 and / or the second port 126. The flow metering devices can include indicators, etc. (e.g., dials, displays, colors, tactile output devices, electrical signal output devices such as wireless radio signals, Bluetooth radio signals, etc.) that can be configured to provide an indication to a user related to a predetermined volume that has been transferred to the pre-sample reservoir 170, the first sample reservoir 180, and / or the second sample reservoir 190. In some embodiments, the flow metering devices can be operably coupled to actuators, etc., such as those described above. In such an embodiment, the flow metering device may be operable to actuate an actuator to move the flow controller 140 between its first configuration and its second configuration based on a desired volume of bodily fluid flowed through the flow metering device. Thus, the flow metering device may be used to ensure that a desired volume of bodily fluid is transferred to the pre-sample reservoir 170, the first sample reservoir 180 and / or the second sample reservoir 190, thereby preventing inadequate, inaccurate and / or erroneous results, such as in microbiological testing on a patient sample.
[0041]
[1094] 2-13, the collection device 200 includes a flow diverter mechanism 220, a flow controller 240, a pre-sample reservoir 270, a first sample reservoir 280, and a second sample reservoir 290 that is different from the first sample reservoir 280. As described further herein, the collection device 200 can be moved between the first, second, and third configurations to deliver a flow of bodily fluid that is substantially free of extracorporeal microorganisms, such as microorganisms present on the skin and / or other undesirable external contaminants. The collection device 200 can be of any suitable shape, size, or configuration. For example, while the sample reservoirs 280 and / or 290 are shown in FIGS. 2-13 as being oriented perpendicularly relative to the housing 201, the collection device 200 can have the sample reservoirs 280 and / or 290 oriented in a plane relative to the housing 201, arranged in a cone relative to the housing 201, etc.
[0042]
[1095] The flow dividing mechanism 220 includes a housing 201 and movable members 250 and 250'. As shown in Figs. 2-4, the housing 201 is coupled to a pre-sample reservoir 270, a first sample reservoir 280, and a second sample reservoir 290. The housing 201 defines an internal flow path 235 that includes an inlet port 221, a first outlet port 230, a second outlet port 231, and a third outlet port 232 and can define a fluid flow path for collecting bodily fluid from a patient. The inlet port 221 can be selectively positioned to be in fluid communication with the internal flow path 235. More specifically, the inlet port 221 defines an inlet lumen 202 that can be positioned to be in fluid communication with the internal flow path 235. In this manner, the inlet port 221 extends from a portion of the housing 201 such that the inlet port 221 can be positioned to be in fluid communication with the internal flow path 235 via the inlet lumen 202 to a space substantially outside the housing 201. The inlet port 221 can be fluidly coupled to a medical device (not shown) defining a fluid flow path for drawing and / or transporting bodily fluid from a patient to the collection device 200. For example, the inlet port 221 can be fluidly coupled to a needle or other lumen-defining device (e.g., flexible sterile tubing) directly or indirectly via the adapter 204. Similarly, the inlet lumen 202 defined by the inlet port 221 is disposed in fluid communication with a lumen defined by the lumen-defining device when the lumen-defining device is coupled to the inlet port 221. More specifically, when the lumen-defining device is disposed within a portion of a patient's body (e.g., within a patient's vein or spinal cavity), the internal flow path 235 of the housing 201 can be disposed in fluid communication with that portion of the patient's body.
[0043]
[1096] The internal flow path 235 defined by the housing 201 is a central lumen extending along the length of the housing 201 that can be placed in fluid communication with a patient's bodily fluid following venipuncture (or other methods employed to allow access to bodily fluids) as described herein. The internal flow path 235 forms a fluid flow path that transports bodily fluids between the inlet port 221 and the first outlet port 230, the second outlet port 231, and the third outlet port 232. More specifically, when the internal flow path 235 is placed in fluid communication with a patient (e.g., via a medical device coupled to the inlet port 221), the first outlet port 230, the second outlet port 231, and the third outlet port 232 can be selectively placed in fluid communication with the internal flow path 235 to allow bodily fluids to flow into at least one of the pre-sample reservoir 270, the first sample reservoir 280, or the second sample reservoir 290. In some embodiments, bodily fluid is prevented from flowing to the second outlet port 231 and the third outlet port 232 before a predetermined volume of bodily fluid is collected in the pre-sample reservoir 270. In some embodiments, the second outlet port 231 and the third outlet port 232 can be arranged to be in fluid communication with the internal flow path 235 simultaneously. In some embodiments, the second outlet port 231 and the third outlet port 232 can be arranged to be in fluid communication with the internal flow path 235 sequentially.
[0044]
[1097] The movable members 250, 250' are configured to be actuated (e.g., moved) by a user from a first position and a second position relative to the housing 201 to direct a fluid flow into the first sample reservoir 280 and the second sample reservoir 290. The movable members 250 and 250' are substantially the same and therefore will be described with respect to a single movable member 250. As shown in FIG. 5, the movable member 250 includes a boss 251 defining an internal cavity 252, an inlet port 253, a first outlet port 254, and a piercing member 255 defining an inner lumen 256 fluidly coupled to the internal cavity 252. The inlet port 253 and the outlet port 254 extend through a wall of the boss 251 that defines the internal chamber 252 of the movable member 250. Movable member 250 is configured to be attached to support 257 (see FIG. 4) of housing 201 such that boss 251 is disposed within bore 258 (see FIG. 4) and at least a portion of movable member 250 is disposed within annular chamber 260. Optionally, a biasing member 259 (e.g., a spring) can be disposed within annular chamber 260 to return movable member 250 to its first position after actuation by a user. In some embodiments, movable member 250, annular chamber 260, bore 258, or boss 251 can include a mechanical locking mechanism configured to hold movable member 250 in a second position (e.g., a depressed position) after actuation by a user.
[0045]
[1098] As described herein, in the first configuration, the movable member 250 is positioned such that it is spaced apart from the internal flow path 235. In such a configuration, no fluid flow path can be established between a portion of the patient's body (e.g., a vein, a spinal cavity, etc.) and the sample reservoirs 280 and / or 290. In other words, when the movable member 250 is in its first configuration, the first sample reservoir 280 and the second sample reservoir 290 are fluidly isolated from the internal flow path 235 defined by the housing 201. The movable member 250 can be actuated by a user to move the movable member 250 from the first configuration to the second configuration and into alignment with the internal flow path 235. The force applied by the user can be sufficient to deform (e.g., compress) the biasing member 259, thereby allowing the piercing member 255 to be inserted into the sample reservoirs 280 and / or 290. In the second configuration, the inlet port 253 and the outlet port 254 are substantially aligned with the internal flow path 235 to place the internal cavity 252 in fluid communication with the internal flow path 235. Thus, when the movable member 250 is in the second configuration, a fluid flow path is established between the internal flow path 235, the internal cavity 252, the lumen 256 of the piercing member 255, and the sample reservoir 280. In other words, in such a configuration, bodily fluid can flow from the patient (e.g., a vein, spinal cavity, etc.), through the flow diversion mechanism 220, and into the first sample reservoir 280 and / or the second sample reservoir 290, as described in more detail herein.
[0046]
[1099] The pre-sample reservoir 270 can be any suitable reservoir for containing bodily fluids, such as, for example, a single-use disposable collection tube, a vacuum collection tube, etc. The pre-sample reservoir 270 is configured to be fluidly coupled to the first outlet port 230 of the collection device 200 in any suitable manner (either directly or via an intervening structure such as a sterile flexible tube). For example, in some embodiments, a portion of the pre-sample reservoir 270 can form a friction fit within a portion of the first outlet port 230. In other embodiments, the pre-sample reservoir 270 can be coupled to the first outlet port 230 via a threaded connection, adhesive, a snap fit, mechanical fasteners, and / or any other suitable coupling method. In some embodiments, the pre-sample reservoir 270 can be integrally formed with the housing 201. Pre-sample reservoir 270 can be configured to maintain a negative pressure condition (vacuum condition) therein that can enable bodily fluid to be drawn from inlet port 221 through outlet port 230 and into pre-sample reservoir 270 via vacuum suction. Pre-sample reservoir 270 is configured to contain a first amount of bodily fluid, which can be a predetermined or unmeasured amount, such that the first amount of bodily fluid is fluidly isolated from a second and / or third amount of bodily fluid that is subsequently drawn from the patient.
[0047]
[1100] Sample reservoirs 280 and / or 290 may be any suitable reservoir for containing bodily fluids, including single-use disposable collection tubes, vacuum collection tubes, sample reservoirs such as those described in the '420 patent, incorporated herein by reference above, and the like. In some embodiments, sample reservoirs 280 and / or 290 may be substantially similar to or the same as known sample containers, such as, for example, Vacutainers. Sample reservoirs 280 and 290 include sample vessels 282 and 292, respectively, and include vacuum seals 284 and 294, respectively. Vacuum seals 284 or 294 maintain a negative pressure (vacuum) within sample vessels 282 or 292, respectively, that may allow bodily fluids to be drawn from internal flow path 235 into sample vessels 282 or 292, respectively, via vacuum suction. The sample vessels 280 and / or 290 can be configured to be fluidly coupled to the second and third outlet ports 231 and 232, respectively, of the collection device 200 in any suitable manner (either directly or via an intervening structure such as a sterile flexible tube). The sample reservoirs 280 and / or 290 can be moved relative to the outlet ports 231 and / or 232 to place them in fluid communication with the outlet ports 231 and / or 232. The sample reservoirs 280 and 290 can be configured to contain a second or third amount of bodily fluid. The second or third amount of bodily fluid can be a predetermined or unmeasured amount, whereby the second or third amount of bodily fluid is fluidly isolated from the first amount of bodily fluid drawn from the patient. In some configurations, the sample reservoirs 280 and / or 290 can be coupled to the collection device 200 by being integrally formed with the housing 201 in the same manner as the pre-sample reservoir 270, and therefore will not be described in detail here. In some cases, sample reservoirs 280 and / or 290 can be transparent, allowing a user to obtain visual feedback to confirm the flow of bodily fluid into sample reservoirs 280 and / or 290.
[0048]
[1101] In some embodiments, the sample reservoirs 280 and 290 and the flow diversion mechanism 220 (and / or portions of the collection device 200 other than the sample reservoirs 280 and 290) are formed separately (e.g., not integrally formed) and are coupled together, for example, during a manufacturing process. In some cases, the sample reservoirs 280 and 290 can be coupled to the flow diversion mechanism 220 in a substantially sterile or sealed environment (e.g., an environment filled with ethylene oxide, etc.). Thus, the interface between the sample reservoirs 280 and 290 and the flow diversion mechanism 220 is substantially sterilized prior to use. Additionally, the collection device 200 can be shipped and / or stored in a pre-assembled manner, such as to maintain a substantially sterile interface between the sample reservoirs 280 and 290 and the flow diversion mechanism 220.
[0049]
[1102] As shown in FIGS. 6 and 7, the flow controller 240 includes a first member 241 and a second member 245. The first member 241 is configured to be disposed within a recess 266 (see, e.g., FIG. 4) of the housing 201, and the first member 241 can be made of any material that is biocompatible, such as, for example, titanium, graphite, pyrolytic carbon, polyester, polycarbonate, polyurethane, elastomeric materials, etc. In some embodiments, the second member 245 acts as an actuator to move the first member 241 from a first configuration to a second configuration. More specifically, when the first member 241 is disposed within the recess 266, the second member 245 can be moved between a first position and a second position to move the flow controller 240 between the first and second configurations. In some embodiments, the housing 201 can selectively limit the movement of the second member 245 from its first position to its second position. In some embodiments, the housing 201 can be configured to prevent movement of the second member 245 once it has been moved to the second position. In other words, the housing 201 can include a locking mechanism that prevents the second member 245 from moving from the second position back to the first position. The second member 245 and / or the housing 201 can also include mechanical detents and / or other indicators that provide visual or tactile feedback to ensure correct positioning of the second member 245.
[0050]
[1103] The first member 241 may include a number of channels that direct fluid flow following venipuncture (and / or other methods of accessing a patient's bodily fluids). For example, as shown in Figures 6 and 7, the first member 241 includes a first flow path 242 and a second flow path 244. When the second member 245 is in a first position (see, e.g., Figures 8 and 9), the flow controller 240 is disposed in a first configuration and the first flow path 242 establishes fluid communication between the inlet port 221 and the first outlet port 230 while fluidly isolating the inlet port 221 from the internal flow path 235. When the second member 245 is in a second position (see, e.g., Figures 10-13), the flow controller 240 is disposed in a second configuration and the second flow path 244 establishes fluid communication between the inlet port 221 and the internal flow path 235 while fluidly isolating the inlet port 221 from the first outlet port 230. Additional first member 241 flow paths and / or additional second member 245 positions corresponding to configurations of flow controller 240 may be included to further direct / isolate fluid flow between the patient and collection device 200. For example, second member 245 may have a third position corresponding to a third configuration of flow controller 240 that substantially prevents fluid flow entirely between the patient and collection device 200. In other words, in some embodiments, after all bodily fluid sample has been removed from the patient, the dial may be moved to the third position to substantially seal the sample within collection device 200 from the outside environment.
[0051]
[1104] In operation, the collection device 200 can be used to collect bodily fluids (e.g., blood) from a patient with reduced contamination from microorganisms present on the skin and / or other undesirable external contaminants. For example, the inlet port 221 of the collection device 200 is fluidly coupled to a needle or other lumen-defining device (e.g., flexible sterile tubing) via the adapter 204. Following venipuncture (or other bodily fluid access method), the second member 245 is rotated until it reaches a first position as shown in FIGS. 8 and 9. Alternatively, the second member 245 can be preset to the first position and the collection device 200 can be sealed in other ways to maintain the vacuum in the pre-sample reservoir 270 and the sterility of the collection device 200. For example, the inlet port 221 and / or the adapter 204 can include a valve that is opened when the collection device 200 is coupled to a needle or other lumen-defining device.
[0052]
[1105] As described above, when second member 245 is in the first position, flow controller 240 is disposed in the first configuration and first flow path 242 of first member 241 establishes fluid communication between inlet port 221 and first outlet port 230 while fluidly isolating inlet port 221 from internal flow path 235. Additionally, first sample reservoir 280 and second sample reservoir 290 are fluidly isolated from inlet port 221 in the first configuration, defining a fluid flow path between a portion of the patient's body (e.g., a vein) and pre-sample reservoir 270, as shown by arrow AA in FIG. As described above, fluid reservoirs used in collection device 200, such as pre-sample reservoir 270 and sample reservoirs 280 and 290, are defined with a negative pressure (i.e., a pressure less than the fluid pressure of the portion of the body from which collection device 200 is being used to draw bodily fluid) such that when fluid communication is established between a portion of a patient's body (e.g., a vein) and pre-sample reservoir 270, the negative pressure in pre-sample reservoir 270 causes bodily fluid to be drawn into pre-sample reservoir 270 due to the pressure differential between pre-sample reservoir 270 and that portion of the patient's body. In this first configuration, flow controller 240 also fluidly isolates pre-sample reservoir 270 from internal flow path 235. Thus, a first amount (predetermined or unmeasured) of bodily fluid can be received into pre-sample reservoir 270 immediately after venipuncture (for example) and isolated from a subsequent sample. In this manner, collection device 200 can be used to ensure that a first volume of bodily fluid that is most likely to contain surface microorganisms and / or other undesirable external contaminants does not contaminate subsequent volumes of bodily fluid sample that are collected and used for diagnostic or other tests that may be affected by the contaminants.
[0053]
[1106] Following collection of the volume of bodily fluid pre-sample in the pre-sample reservoir 270, the second member 245 can be rotated until it reaches a second position as shown in Figures 10 and 11. When the second member 245 is in the second position, the flow controller 240 is disposed in a second configuration and the second flow path 244 of the first member 241 establishes fluid communication between the inlet port 221 and the internal flow path 235 while fluidly isolating the first outlet port 230 (i.e., the pre-sample reservoir 270) from the inlet port 221. In other words, in the second configuration, the flow controller 240 establishes a fluid flow path between a portion of the patient's body (e.g., a vein) and the internal flow path 235 via the second flow path 244 as shown by arrow BB in Figure 11.
[0054]
[1107] With the flow controller 240 in the second configuration, the movable members 250 and / or 250' can be actuated (i.e., depressed) by a user from a first position to a second position to establish fluid communication between a portion of a patient's body (e.g., a vein) and the first sample reservoir 280 and / or the second sample reservoir 290. More specifically, the movable member 250 moves from its first position to its second configuration such that the piercing member 255 passes through the exit port 231 such that the piercing member 255 can pierce the vacuum seal 284 of the first sample reservoir 280 and be disposed within the sample container 282, as shown by arrow CC in FIG. When in the second position, the inlet port 253 and the outlet port 254 of the movable member 250 are substantially aligned with and in fluid communication with the internal flow path 235, thereby allowing bodily fluid to flow from the internal flow path 235 into the internal cavity 252 of the movable member 250 and out of the lumen 256 of the piercing member 255 into the first sample reservoir 280. A pressure difference between the sample reservoir 280 (e.g., vacuum or negative pressure) and the internal flow path 235 draws bodily fluid into the sample reservoir 280. In other words, in the second configuration, the movable member 250 establishes a fluid flow path between the internal flow path 235 and the first sample reservoir 280, as shown by arrows DD in FIG. 12. Once a desired amount (e.g., a second amount) of bodily fluid has been collected in the first sample reservoir 280, the user can release the movable member 250 to allow the biasing member 259 to move the button back to its first position. When the movable member 250 returns to its first position, the piercing member 255 is removed from the first sample reservoir 280 and a seal 284 (eg, a self sealing septum) fluidly isolates the first sample reservoir 280 from the internal flow path 235.
[0055]
[1108] Similarly, while the flow controller 240 is in the second configuration, the movable member 250' can be actuated (depressed) by a user from its first position to its second position, as shown by arrow EE in FIG. 13. In this manner, fluid communication is established (via the outlet port 232) between a portion of the patient's body (e.g., a vein) and the second sample reservoir 290 in a manner similar to that of the movable member 250 and the first sample reservoir 280 described above. In other words, in the second configuration, the movable member 250' establishes a fluid flow path between the internal flow path 235 and the second sample reservoir 290, as shown by arrow FF in FIG. 13. Once a desired amount (e.g., a third amount) of bodily fluid has been collected in the second sample reservoir 290, the user can release the movable member 250' to allow the biasing member 259' to move the button 250' back to its first position. Although shown and described as being a sequential process, the order and / or sequencing of filling is not necessarily required (i.e., sample reservoir 280 does not necessarily have to be filled before sample reservoir 290, etc.). In other words, when flow controller 240 moves to the second configuration, first sample reservoir 280 and second sample reservoir 290 (and any additional sample reservoirs) can be filled in any order, at the same time (e.g., simultaneously) and / or with overlapping time intervals. For example, a user can begin filling first sample reservoir 280, and then, after first sample reservoir 280 is partially filled, the user can press movable member 250' to begin filling second sample reservoir 290 while first sample reservoir 280 finishes filling. Additionally, adjustment of the volume of bodily fluid collected in sample reservoirs 280 and / or 290 may be permitted by repeatedly actuating (inserting) movable members 250 and / or 250'. As described above, second member 245 may have a third position corresponding to a third configuration of flow controller 240, which may substantially prevent fluid flow between the patient and collection device 200 altogether to substantially seal the sample in collection device 200 from the external environment.
[0056]
[1109] Although not shown in FIGS. 2-13, the collection device 200 may include a flow metering device or the like that may be configured to meter a volume of bodily fluid transferred to the pre-sample reservoir 270, the first sample reservoir 280, and / or the second sample reservoir 290. For example, in some embodiments, the first member 241 of the flow controller 240 may include a flow metering device in fluid communication with the first flow path 242 and the second flow path 244. In other embodiments, the flow metering device may be disposed within the internal cavity 252 of the movable member 250 and / or 250′. Thus, the volume of bodily fluid sample transferred to and disposed within the first sample reservoir 280 and the second sample reservoir 290 may be metered and / or controlled such that the volume of bodily fluid sample disposed within each sample reservoir 280 and 290 is a predetermined volume, e.g., 10 mL, 20 mL, 30 mL, etc.
[0057]
[1110] Although the collection device 200 is shown and described as including a first sample reservoir 280 and a second sample reservoir 290, in other embodiments, the collection device 200 may include any number of pre-sample reservoirs and / or sample reservoirs. For example, Figures 14 and 15 show a collection device 300 according to an embodiment. As shown, some aspects of the collection device 300 may be substantially similar to corresponding aspects of the collection device 200 described above with reference to Figures 2-13. As such, similar aspects will not be described in further detail herein.
[0058]
[1111] As shown in FIGS. 14 and 15, the collection device 300 includes a flow splitter mechanism 320, a flow controller 340, a pre-sample reservoir 370, a first sample reservoir 380, a second sample reservoir 380', a third sample reservoir 390, and a fourth sample reservoir 390'. The pre-sample reservoir 370 can be substantially similar to the pre-sample reservoir 270 described in detail above. In some embodiments, the sample reservoirs 380, 380', 390, and 390' can be substantially similar to the sample reservoirs 280 and 290 described in detail above. In some embodiments, the sample reservoirs 380, 380', 390, and 390' can have substantially the same shape and size, and can include substantially the same medium, for example. In other embodiments, the sample reservoirs 380, 380', 390, and 390' can have substantially the same shape and size, and can include one of an aerobic medium or an anaerobic medium. For example, in some embodiments, the first sample reservoir 380 and the third sample reservoir 390 can contain aerobic medium and the second sample reservoir 380' and the fourth sample reservoir 390' can contain anaerobic medium. In other embodiments, the sample reservoirs 380, 380', 390 and 390' can each contain aerobic or anaerobic medium in any arrangement or combination.
[0059]
[1112] Flow diverter mechanism 320 includes a housing 301 and a set of movable members 350, 350', 350'', and 350''', which are substantially similar to movable members 250 described above, for example with reference to FIG. 5. As such, movable members 350, 350', 350'', and 350''' can be moved between first and second positions relative to housing 301 such that they are disposed in fluid communication with sample reservoirs 380, 380', 390, and 390', respectively. The housing 301 includes an inlet port 321, a first outlet port 330 configured to be disposed in fluid communication with a pre-sample reservoir 370, a second outlet port 331 configured to be disposed in fluid communication with a first sample reservoir 380, a third outlet port 332 configured to be disposed in fluid communication with a second sample reservoir 380', a fourth outlet port 333 configured to be disposed in fluid communication with a third sample reservoir 390', and a fifth outlet port 334 configured to be disposed in fluid communication with a fourth sample reservoir 390'. Additionally, the housing 301 defines an internal flow path 335 that can be selectively disposed in fluid communication with the inlet port 321 and the outlet ports 331, 332, 333 and 334 in a manner similar to that described above with respect to the internal flow path 235 of the housing 201.
[0060]
[1113] The flow controller 340 is substantially similar to the flow controller 240 described above with reference to, for example, Figures 6-13. Thus, the flow controller 340 can be rotated between a first configuration and a second configuration to selectively define a portion of a fluid flow path between the patient and the pre-sample reservoir 370 or the sample reservoirs 380, 380', 390 and 390'. In this manner, a user can operate the collection device 300 in a manner similar to that described above with respect to the collection device 200 in Figures 8-13. Thus, a first volume of bodily fluid can be transferred and disposed in the pre-sample reservoir 370, and subsequent volumes of bodily fluid can be transferred and disposed in the sample reservoirs 380, 380', 390 and 390'.
[0061]
[1114] 16-22 show a collection device 400 according to an embodiment. The collection device 400 includes a flow diverter mechanism 420, a flow controller 440, and sample reservoirs 480, 480', 490, and 490'. As described further herein, the collection device 400 can be moved between a first configuration, a second configuration, a third configuration, a fourth configuration, and a fifth configuration to deliver a flow of bodily fluid that is substantially free of extracorporeal microorganisms, such as microorganisms present on the skin and / or other undesirable external contaminants. The collection device 400 can be of any suitable shape, size, or configuration. For example, although the sample reservoirs 480, 480', 490, and 490' are shown oriented perpendicularly relative to the housing 401 in FIGS. 16-22, the collection device 400 can have the sample reservoirs 480, 480', 490, and 490' oriented in any suitable plane relative to the housing 401, or arranged conically relative to the housing 401, etc.
[0062]
[1115] Sample reservoirs 480, 480', 490 and 490' are substantially similar or identical in form and function to sample reservoirs 280 and / or 290 of collection device 200 and therefore will not be described in detail herein. As discussed above, sample reservoirs 480, 480', 490 and 490' maintain a negative pressure (vacuum) that can allow for drawing bodily fluids from a patient into sample reservoirs 480, 480', 490 and 490' via suction. In some embodiments, sample reservoirs 480 and 480' can be aerobic culture bottles and sample reservoirs 490 and 490' can be anaerobic culture bottles, and collection device 400 can be used to collect multiple aerobic and multiple anaerobic blood culture samples from a single venipuncture. As described in more detail herein, sample reservoirs 480, 480', 490, and 490' can each be disposed in fluid communication with at least a portion of flow diversion mechanism 420 to receive a volume of a bodily fluid sample. The volume of the bodily fluid sample can be a predetermined or undetermined amount. Furthermore, once a desired volume of bodily fluid has been disposed in sample reservoirs 480, 480', 490, and 490', each sample reservoir 480, 480', 490, and 490' can be fluidly isolated from at least a portion of flow diversion mechanism 420, as described in more detail herein.
[0063]
[1116] The flow diverter mechanism 420 includes a housing 401 and a distribution member 429. The housing 401 of the flow diverter mechanism 420 is physically and fluidly coupled to the distribution member 429 to provide and / or define a set of fluid flow paths for collecting bodily fluid from a patient. The housing 401 defines a recess 466 and a set of outlet openings 403. The recess 466 is configured to receive a seal member 441 included in the flow controller 440, as described in further detail herein. The set of outlet openings 403 includes a first outlet opening 403a, a second outlet opening 403b, a third outlet opening 403c, a fourth outlet opening 403d, and a fifth outlet opening 403e, each configured to define a different fluid flow path in fluid communication with a different portion of the distribution member 429. More specifically, the distribution member 429 defines and / or forms at least a portion of the pre-sample reservoir 470 in fluid communication with the first outlet opening 403a, a first flow path 435a in fluid communication with the second outlet opening 403b, a second flow path 435b in fluid communication with the third outlet opening 403, a third flow path 435c in fluid communication with the fourth outlet opening 403d, and a fourth flow path 435 in fluid communication with the fifth outlet opening 403e.
[0064]
[1117] 17 and 18, the distribution member 429 defines a chamber or space that defines at least a portion of the pre-sample reservoir 470. The pre-sample reservoir 470 is configured to contain a bodily fluid, such as, for example, blood, plasma, urine, etc. The first outlet opening 403a of the housing 401 can be substantially aligned with the open portion of the pre-sample reservoir 470 to allow the pre-sample reservoir 470 to receive a flow of the bodily fluid from the patient. For example, the pre-sample reservoir 470 can receive and contain a first amount or volume of the bodily fluid, where the first amount of the bodily fluid can be a predetermined amount or an undetermined amount. Additionally, the arrangement of the flow diverter mechanism 420 can be such that the pre-sample reservoir 470 is maintained in fluid isolation from the flow paths 435a, 435b, 435c, and 435d and / or a subsequent volume of bodily fluid drawn from the patient, as described in more detail herein. Although pre-sample reservoirs 270 and 370 are described above as maintaining a negative pressure, pre-sample reservoir 470 does not maintain a negative pressure (vacuum) and therefore bodily fluid can be drawn into pre-sample reservoir 470 using other mechanisms, such as gravity.
[0065]
[1118] The flow paths 435a-435d extend radially from the center of the distribution member 429 and are arranged such that each of the flow paths 435a, 435b, 435c, and 435d is fluidically isolated from the pre-sample reservoir 470 and the other flow paths. In this manner, the flow paths 435a, 435b, 435c, and 435d can be oriented and / or otherwise defined as fluid flow paths between first and second ends that are substantially aligned with the outlet openings 403b, 403c, 403d, and 403e, respectively. As shown in FIGS. 17 and 18, the distribution member 429 defines a first outlet port 431 disposed at the second end of the first flow path 435a, a second outlet port 432 disposed at the second end of the second flow path 435b, a third outlet port 433 disposed at the second end of the third flow path 435c, and a fourth outlet port 434 disposed at the second end of the fourth flow path 435d. Additionally, distribution member 429 includes first piercing member 455a, second piercing member 455b, third piercing member 455c, and fourth piercing member 455d, which are physically and fluidly coupled to first outlet port 431, second outlet port 432, third outlet port 433, and fourth outlet port 434, respectively. Thus, as described in more detail herein, piercing members 455a-d can be used to pierce the vacuum seals of sample reservoirs 480, 480', 490, and 490', thereby initiating the flow of bodily fluids. Although not shown in Figures 17 and 18, sample reservoirs 480, 480', 490 and 490' may be physically coupled to a portion of distribution member 429 (directly or via an intervening structure such as a sterile flexible tube) in any suitable manner that can enable sample reservoirs 480, 480', 490 and 490' to be positioned in fluid communication with outlet ports 431, 432, 433 and 434, respectively.
[0066]
[1119] The flow controller 440 includes a dial 445 and a seal member 441. The seal member 441 is disposed within a recess 466 of the housing 401 (see, e.g., FIG. 20 ). More specifically, the flow controller 440 can be coupled to the housing 401 such that the seal member 441 is disposed between and in contact with a surface of the housing 401 that defines the recess 466 and a surface of the dial 445. Furthermore, the seal member 441 can have a size and shape such that when the flow controller 440 is coupled to the housing 401, the seal member 441 forms a substantially fluid-tight seal with a surface of the dial 445 and a surface of the housing 401 that defines the recess 466, as described in more detail herein. The sealing member 441 can be made from any material that is biocompatible, such as, for example, silicone, polylactic acid, polyglycolic acid, polylactic-co-glycolic acid (PLGA), polyanhydrides, polyorthoesters, polyetheresters, polycaprolactone, polyesteramides, poly(butyric acid), poly(valeric acid), polyurethanes, nylons, polyesters, polycarbonates, polyacrylates, polymers of ethylene-vinyl acetate and other acyl-substituted cellulose acetates, polystyrene, polyvinyl chloride, polyvinyl fluoride, poly(vinylimidazole), chlorosulfonated polyolefins, polyethylene oxide, and / or mixtures and copolymers thereof.
[0067]
[1120] 17, the seal member 441 defines a set of openings 444 through which bodily fluid flow can be directed following venipuncture (or other method of accessing bodily fluid). For example, the set of openings 444 defined by the seal member 441 includes a first opening 444a, a second opening 444b, a third opening 444c, a fourth opening 444d, and a fifth opening 444e. The seal member 441 is disposed such that when the seal member 441 is disposed within the recess 446, the first opening 444a, the second opening 444b, the third opening 444c, the fourth opening 444d, and the fifth opening 444e are substantially aligned with the first outlet opening 403a, the second opening 403b, the third opening 403c, the fourth opening 403d, and the fifth opening 403e of the housing 401, respectively.
[0068]
[1121] A dial 445 of the flow controller 440 is rotatably coupled to the housing 401 and is movable between a first position, a second position, a third position, a fourth position, and a fifth position relative to the housing 401. The dial 445 includes an inlet port 421 that defines a lumen 402. The inlet port 421 can be fluidly coupled to a medical device (not shown) that defines a fluid flow path for withdrawing and / or transporting bodily fluid from within a patient's body to the collection device 400. For example, the inlet port 421 can be fluidly coupled to a needle or other lumen-defining device (e.g., flexible sterile tubing) directly or indirectly via an adapter 404. Similarly, the inlet lumen 402 defined by the inlet port 421 is disposed to be in fluid communication with a lumen defined by the lumen-defining device when the lumen-defining device is coupled to the inlet port 421. In this manner, the inlet port 421 can be configured to selectively place the pre-sample reservoir 470, the first sample reservoir 480, the second sample reservoir 480', the third sample reservoir 490 and the fourth sample reservoir 490' in fluid communication with the patient, as described in further detail herein.
[0069]
[1122] As described above, the dial 445 is movable between a first position, a second position, a third position, a fourth position, and a fifth position. When the dial 445 is in the first position, the flow controller 440 is disposed in a first configuration, and the inlet port 421 may be substantially aligned with the first opening 444a of the seal member 441 and the first outlet opening 403a of the housing 401. In this manner, the first opening 444a of the seal member 441 fluidly isolates the inlet port 421 from the outlet openings 403b, 403c, 403d, and 403e, thereby establishing fluid communication between the inlet port 421 and the first outlet opening 403a while fluidly isolating the inlet port 421 from the flow paths 435a-d. When the first outlet port 403a is aligned with the open portion of the pre-sample reservoir 470, the first opening 444a and the first outlet opening 403a establish fluid communication between the inlet port 421 and the pre-sample reservoir 470. When the dial 445 is rotated (or actuated) to the second position, the flow controller 440 is placed in the second configuration and the second outlet opening 444b establishes fluid communication between the inlet port 421 and the second outlet opening 403b while fluidly isolating the inlet port 421 from the outlet openings 403a, 403c, 403d, and 403e. When the second outlet opening 403b is aligned with the first end of the first flow path 435a, the second opening 444b and the second outlet opening 403b establish fluid communication between the inlet port 421 and the first flow path 435a.
[0070]
[1123] The collection device 400 operates similarly when the dial 445 is rotated to the third, fourth and fifth positions. Thus, when the inlet lumen 402 is placed in fluid communication with a patient (e.g., via a medical device coupled to the inlet port 421), the first outlet port 430, the second outlet port 431, the third outlet port 432, the fourth outlet port 433 and the fifth outlet port 434 can be selectively placed in fluid communication with the inlet lumen 402 to allow all of the bodily fluid to flow into at least one of the pre-sample reservoirs 470 or one or more of the sample reservoirs 480, 480', 490 and 490'. In some embodiments, additional dial 445 positions corresponding to additional seal outlet openings and / or configurations of the flow controller 440 can be included to further direct / isolate the fluid flow between the patient and the collection device 400. For example, the dial 445 can have a sixth position that corresponds to a sixth configuration of the flow controller 440 that generally substantially prevents fluid flow between the patient and the collection device 400. In other words, in some embodiments, after all of the bodily fluid sample has been removed from the patient, the dial 445 can be moved to the sixth position to substantially seal the sample within the collection device 400 from the outside environment.
[0071]
[1124] In some embodiments, bodily fluid is prevented from flowing to an outlet port associated with a sample reservoir (e.g., outlet ports 431-434) until after a predetermined volume of bodily fluid has been collected in pre-sample reservoir 470. In some embodiments, the outlet ports associated with the sample reservoirs (e.g., outlet ports 431-434) can be arranged to be in fluid communication with inlet lumen 402 only sequentially (e.g., outlet port 431 must be in fluid communication with inlet lumen 402 before outlet port 432, etc.). In some embodiments, the outlet port associated with a subsequent sample reservoir (e.g., outlet ports 432-434) can be arranged to be in fluid communication with inlet lumen 402 only after a determined volume of bodily fluid has been collected. In some embodiments, the outlet ports associated with the sample reservoirs (e.g., outlet ports 431-434) can be arranged to be fluidly connected to the inlet lumen 402 in any random manner without any order preference (e.g., outlet port 434 can be fluidly connected to the inlet lumen 402 before outlet port 431, outlet port 432 can be fluidly connected to the inlet lumen 402 before outlet port 433, etc.).
[0072]
[1125] In some embodiments, the housing 401 can selectively limit movement of the dial 445 from its first position to its second, third, fourth, and fifth positions. In some embodiments, the housing 401 can be configured to prevent movement of the dial 445 once it has been moved to the fifth position. In other words, the housing 401 can include a locking mechanism that prevents the dial 445 from moving from the fifth position back to the first position. The dial 445 and / or the housing 401 can also include mechanical detents and / or other indicators that provide visual or tactile feedback to ensure correct positioning of the dial 445 relative to the outlet openings 403a-403e of the housing 401.
[0073]
[1126] In operation, the collection device 400 can be used to collect bodily fluids (e.g., blood, plasma, urine, etc.) from a patient with reduced contamination. For example, the inlet port 421 of the collection device 400 can be fluidly coupled to a needle or other lumen-defining device (e.g., flexible sterile tubing). Following venipuncture (or other method of accessing bodily fluids), the dial 445 is actuated (or turned) until it reaches a first position, as shown in FIGS. 19 and 20 . Alternatively, the dial 445 can be preset to the first position, and the collection device 400 can be sealed in other ways to maintain the sterility of the collection device 400. For example, the inlet port 421 can include a valve that opens when the collection device 400 is coupled to a needle or other lumen-defining device.
[0074]
[1127] As described above, when dial 445 is in the first position, flow controller 440 is placed in a first configuration, and first opening 444a of seal member 441 establishes fluid communication between inlet port 421 (contained within housing 401) and first outlet port 430 while fluidly isolating inlet port 421 from the four flow paths 435a-d. Additionally, sample reservoirs 480, 480', 490 and 490' are fluidly isolated from inlet port 421 in the first configuration, defining a fluid flow path between a portion of the patient's body (e.g., a vein) and pre-sample reservoir 470, as shown by arrows GG in FIG. 20. In this first configuration, bodily fluid flows (e.g., by gravity, vacuum, etc.) from that portion of the patient's body through inlet lumen 402 of inlet port 421, first opening 444a of seal member 441, first outlet port 430, and into pre-sample reservoir 470. In the first configuration, the flow controller 440 also fluidly isolates the pre-sample reservoir 470 from the flow paths 435a-335d. Thus, a first amount of bodily fluid (predetermined or undetermined) can be received into the pre-sample reservoir 470 immediately following venipuncture and isolated from subsequent samples. In this manner, the collection device 400 can be used to ensure that the first amount of bodily fluid, which is most likely to contain surface microorganisms and / or other undesirable external contaminants, does not contaminate subsequent amounts of bodily fluid sample collected and used for diagnostic or other tests that may be affected by the contaminants.
[0075]
[1128] Following collection of the bodily fluid pre-sample in the pre-sample reservoir 470, the dial 445 can be actuated (rotated) until it reaches a second position, as shown in FIGS. 21 and 22. When the dial 445 is in the second position, the flow controller 440 is placed in the second configuration, and the second opening 444b of the seal member 441 establishes fluid communication between the inlet port 421 and the flow path 435a while fluidly isolating the pre-sample reservoir 470 from the inlet port 421. In other words, in the second configuration, the flow controller 440 establishes a fluid flow path between a portion of the patient's body (e.g., a vein) and the flow path 435a, as shown by the arrow HH in FIG. 22. With the flow controller 440 in the second configuration, the sample reservoir 480 can be actuated (e.g., by pushing the piercing member 455a) by a user from the first configuration to the second configuration to establish fluid communication between a portion of the patient's body (e.g., a vein) and the first sample reservoir 480.
[0076]
[1129] As described above, by moving the sample reservoir 480 to the second configuration, the piercing member 455a is positioned inside the sample reservoir 480, piercing the vacuum seal of the sample reservoir 480. In this second configuration, a portion of the patient's body (e.g., a vein) is exposed to a vacuum suction force from the sample reservoir 480 due to a negative pressure condition (vacuum) within the sample reservoir 480. The pressure difference between the sample reservoir 480 (e.g., vacuum or negative pressure) and the portion of the patient's body draws bodily fluid into the sample reservoir 480. The bodily fluid flows from the portion of the patient's body through the inlet lumen 402 of the inlet port 421, the second opening 444b of the seal member 441, the second outlet opening 403b of the housing 401, and into the first flow path 435a. The vacuum suction draws a flow of bodily fluid through the first flow path 435a, through the second outlet port 431 and the piercing member 455a, and into the sample reservoir 480. In other words, in the second configuration, the flow controller 440 establishes a fluid flow path between the inlet port 421 and the sample reservoir 480. Once a desired amount (e.g., a second amount) of bodily fluid has been collected in the sample reservoir 480, the user can actuate (rotate) the flow controller 440 to a third position and / or move the sample reservoir 480 back to its first configuration to isolate the first sample reservoir 480 from the flow path 435a. Once the sample reservoir 480 is back to the first configuration, the piercing member 455a is removed from the sample reservoir 480, and a seal (e.g., a self-sealing membrane) of the sample reservoir 480 isolates the first sample reservoir 480 from the flow path 435a. Filling of the other sample reservoirs is similarly accomplished with flow controller 440 disposed in the third, fourth, and fifth configurations, respectively.
[0077]
[1130] It should be noted that the order and / or sequencing of filling is not necessarily required (i.e., sample reservoir 480 does not necessarily have to be filled before sample reservoir 490, etc.). In other words, the first sample reservoir 480 and the second sample reservoir 490 (and any additional sample reservoirs) can be filled in any order. For example, a user can begin filling the first sample reservoir 480, and then, after the first sample reservoir 480 is partially filled, the user can fill the second sample reservoir 490. Additionally, repeated filling of sample reservoirs 480 and / or 490 can allow for adjustment of the volume of bodily fluid collected in the sample reservoirs 480 and / or 490. However, in other embodiments, the order of filling can be mechanically manipulated, such as not allowing access to the second sample reservoir until a specified amount of bodily fluid has been confirmed to be placed in the first reservoir. As described above, the dial 445 can have a sixth position for the sixth configuration of the flow controller 440 that can substantially prevent fluid flow between the patient and the collection device 400 as a whole, thereby substantially sealing the sample within the collection device 400 from the external environment.
[0078]
[1131] Although the collection device 400 is shown and described above as including and / or otherwise coupled to a set of four sample reservoirs (e.g., a first sample reservoir 480, a second sample reservoir 480', a third reservoir 490, and a fourth reservoir 490'), in other embodiments, the collection device may include and / or be coupled to any suitable number of sample reservoirs. For example, FIGS. 23-25 show a collection device 500 according to an embodiment. As shown, some aspects of the collection device 500 may be substantially similar to corresponding aspects of the collection device 500 described above with reference to FIGS. 16-22. Accordingly, similar aspects will not be described in further detail herein.
[0079]
[1132] The collection device 500 includes a flow splitter mechanism 520, a flow controller 540, a first sample reservoir 580, and a second sample reservoir 590. The sample reservoirs 580 and 590 can be substantially similar to the sample reservoirs described in detail above. In some embodiments, the sample reservoirs 580 and 590 can have substantially the same shape and size and can contain substantially the same medium. In other embodiments, the sample reservoirs 580 and 590 can have substantially the same shape and size and can contain one of an aerobic medium or an anaerobic medium. In yet other embodiments, the first sample reservoir 580 can have a first size that is substantially larger than the size of the second sample reservoir 590.
[0080]
[1133] As shown in FIGS. 24 and 25, the flow diverter structure 520 includes a housing 501 and a distribution member 529. The housing 501 of the flow diverter structure 520 is physically and fluidly coupled to the distribution member 529 to provide and / or define a set of fluid flow paths for collecting bodily fluid from a patient. As described above with respect to the housing 401, the housing 501 can define a recess and a first outlet opening 503a, a second outlet opening 503b, and a third outlet opening 503c. The recess is configured to receive a seal member 541 included in the flow controller 540, as described in detail above. The first outlet opening 503a, the second outlet opening 503b, and the third outlet opening 503c can be substantially similar in form and function to the first outlet opening 403a, the second outlet opening 403b, and the third outlet opening 403c, respectively, defined by the housing 401. Similarly, the distribution member 529 defines a pre-sample reservoir 470, a first flow path 435a, and a second flow path 435b that are substantially similar to the pre-sample reservoir 470, the first flow path 435a, and the second flow path 435b included in the flow dividing member 429. Thus, as described above with respect to the flow dividing mechanism 420, the pre-sample reservoir 570 is in fluid communication with the first outlet opening 503a, the first flow path 535a is in fluid communication with the second outlet opening 503b, and the second flow path 535b is in fluid communication with the third outlet opening 503c. As shown in FIG. 25, the distribution member 529 defines a first outlet port 531 in fluid communication with the first flow path 535a and the first piercing member 555a, and a second outlet port 532 in fluid communication with the second flow path 535b and the second piercing member 555b. As mentioned above, piercing members 555a and 555b can be used to pierce the vacuum seals of sample reservoirs 580 and 590, thereby initiating the flow of bodily fluids, as described in more detail herein.
[0081]
[1134] The flow controller 540 includes a dial 545 and a seal member 541. The seal member 541 is disposed within a recess in the housing 501, as described above. Thus, when the flow controller 540 is coupled to the housing 501, the seal member 541 forms a substantially fluid-tight seal with a surface of the dial 545 and a surface of the housing 501 that defines the recess. As shown in Figures 24 and 25, the seal member 541 defines a first opening 544a, a second opening 544b and a third opening 544c that are substantially aligned with the first exit opening 503a, the second exit opening 503b and the third exit opening 503c, respectively, as described in detail above with respect to the seal member 441.
[0082]
[1135] The dial 545 of the flow controller 540 may be substantially similar in form and function to the dial 445, while being suitably sized to be coupled to the housing 501. Thus, the dial 545 may be rotatably coupled to the housing 501 and movable relative to the housing 501 between a first position, a second position, and a third position. The dial 545 includes an inlet port 521 defining a lumen 502, the inlet port 521 may be fluidly coupled to a medical device (not shown) defining a fluid flow path for drawing and / or transporting bodily fluid from a patient to the collection device 500. As such, the inlet port 521 may be configured to selectively position the pre-sample reservoir 570, the first sample reservoir 580, and the second sample reservoir 590. More particularly, when the dial 545 is in the first position, the flow controller 540 is disposed in a first configuration and the inlet port 521 is substantially aligned with the first opening 544a of the seal member 541 and the first outlet opening 503a of the housing 501. Thus, as described in detail above with respect to collection device 400, first opening 544a of seal member 541 establishes fluid communication between inlet port 521 and first outlet opening 503a, thus placing inlet port 521 in fluid communication with pre-sample reservoir 570. Similarly, when dial 545 is turned (or actuated) to the second position, flow controller 540 is placed in the second configuration and second outlet opening 544b establishes fluid communication between inlet port 521 and second outlet opening 503b, and thus first flow path 535a, and when dial 545 is turned to the third position, flow controller 540 is placed in the third configuration and third outlet opening 544c establishes fluid communication between inlet port 521 and third outlet opening 503c, and thus second flow path 535a. In this manner, as described in detail above with respect to collection device 400, collection device 500 can be used to transfer a first volume of bodily fluid to pre-sample 570 and then to transfer second and third volumes of bodily fluid to first sample reservoir 580 and second sample reservoir 590, respectively.
[0083]
[1136] 26-33 show a collection device 600 according to an embodiment. The collection device 600 includes a flow diverter mechanism 620, a flow controller 640, and sample reservoirs 680, 680', 690, and 690'. As described further herein, the collection device 600 can be moved between a first configuration, a second configuration, a third configuration, a fourth configuration, and a fifth configuration to deliver a flow of bodily fluid that is substantially free of extracorporeal microorganisms, such as microorganisms present on the skin and / or other undesirable external contaminants. The collection device 600 can be of any suitable shape, size, or configuration. For example, aspects and / or portions of the collection device 600 can be similar in form and / or function to corresponding aspects and / or portions of any of the collection devices 100, 200, 300, 400, and / or 500 described above. As such, such similar aspects and / or portions will not be described in further detail herein. By way of example, in some embodiments, sample reservoirs 680, 680', 690 and 690' of collection device 600 may be substantially similar and / or identical in form and / or function to sample reservoirs 480, 480', 490 and 490', respectively, included in collection device 400 of Figures 16-22.
[0084]
[1137] The flow splitter mechanism 620 includes a distribution member 629 and a set of coupling members 637a, 637b, 637c, and 637d (see, e.g., FIG. 27). The distribution member 629 is in fluid communication with the coupling members 637a, 637b, 637c, and 637d and is configured to provide and / or define a set of fluid flow paths for collecting bodily fluid from a patient. As shown in FIGS. 27 and 28, the distribution member 629 defines and / or forms a first outlet port 630 in fluid communication with the pre-sample reservoir 670, a second outlet port 631 in fluid communication with the first coupling member 637a, a third outlet port 632 in fluid communication with the second coupling portion 637b, a fourth outlet port 633 in fluid communication with the third coupling portion 637c, and a fifth outlet port 634 in fluid communication with the fourth coupling portion 637d.
[0085]
[1138] 28, the distribution member 629 defines a chamber or space that defines at least a portion of a pre-sample reservoir 670. The pre-sample reservoir 670 is configured to contain a bodily fluid, such as, for example, blood, plasma, urine, etc. For example, the pre-sample reservoir 670 can receive and contain a first amount or volume of bodily fluid from a patient, where the first amount of bodily fluid can be a predetermined amount or an undetermined amount. Additionally, the arrangement of the flow diverter mechanism 620 and the flow controller 640 can be such that the pre-sample reservoir 670 is maintained in fluid isolation from the coupling portions 637a, 637b, 637c, and 637d and / or a subsequent volume of bodily fluid drawn from the patient, as described in more detail herein. In this manner, outlet ports 631, 632, 633, and 634 can direct and / or otherwise define a fluid flow path between flow controller 640 and coupling members 637a, 637b, 637c, and 637d, respectively, as described in further detail herein. In some embodiments, the arrangement of first outlet port 630 and pre-sample reservoir 670 can be substantially similar in form and function to pre-sample reservoirs 470 and / or 570. Accordingly, pre-sample reservoir 670 will not be described in further detail herein.
[0086]
[1139] As shown in FIG. 29, the first coupling member 637a defines a flow passage 638a that is fluidly coupled to the piercing member 655a. As described above, the coupling member 637a can be physically and fluidly coupled to the distribution member 629. For example, the flow passage 638a can receive a portion of the second outlet port 631 of the distribution member to physically and fluidly couple the coupling member 637a thereto. In some embodiments, a surface of the second outlet port 631 can form a substantially fluid-tight seal (e.g., a friction fit that can form a substantially air-tight seal) with an inner surface of the coupling portion 637a that defines the flow passage 638a. The piercing member 655a of the coupling portion 637a can be substantially similar in form and function to the piercing member 455a included in the collection device 400 of FIGS. 16-22. Thus, the piercing member 655a will not be described further herein. The second coupling member 637b, the third coupling member 637c, and the fourth coupling member 637d are similarly arranged. Thus, the second coupling member 637b, the third coupling member 637c and the fourth coupling member 637d each include a piercing member 655b, 655c and 655d, respectively, and define a flow path 638b, 638c and 638d, respectively. As described in more detail herein, the first coupling member 637a, the second coupling member 637b, the third coupling member 637c and the fourth coupling member 637d can be used to selectively position the flow splitter structure 620 in fluid communication with the first sample reservoir 680, the second sample reservoir 680', the third sample reservoir 690 and the fourth sample reservoir 690', respectively.
[0087]
[1140] As shown in FIGS. 30 and 31, the flow controller 640 includes a dial 645 and a seal member 641. The dial 645 of the flow controller 640 is rotatably disposed within the distribution member 629 (see FIGS. 32 and 33) and is movable between a first position, a second position, a third position, and a fourth position. The dial 645 includes an inlet port 621, a first outlet port 647, and a second outlet port 648, each of which is fluidly connected to an interior space 646 (see, e.g., FIG. 30). The interior space 646 is configured to receive a portion of the seal member 641, as described in more detail herein. The inlet port 621 can be fluidly coupled to a medical device (not shown) that defines a fluid flow path for drawing and / or transporting bodily fluid from a patient to the collection device 600. For example, the inlet port 621 can be fluidly coupled to a needle or other lumen-defining device (e.g., flexible sterile tubing) directly or indirectly via an adapter 604 (see, e.g., FIGS. 26 and 27). The first outlet port 647 is in fluid communication with the pre-sample reservoir 670. For example, the first outlet port 647 can be rotatably disposed within the first outlet port 630 of the distribution member 629. The second outlet port 648 can be selectively disposed to be in fluid communication with the second outlet port 631, the third outlet port 632, the fourth outlet port 633, and the fifth outlet port 634 when the dial 645 is in its first, second, third, and fourth positions, respectively. In this manner, the interior space 646 of the dial 645 can be selectively disposed to be in fluid communication with the pre-sample reservoir 670, the first sample reservoir 680, the second sample reservoir 680', the third sample reservoir 690, and the fourth sample reservoir 690', as described in further detail herein.
[0088]
[1141] At least a portion of the seal member 641 of the flow controller 640 is rotatably disposed within the interior space 646 of the dial 645 and is movable between a first position and a second position. Further, the seal member 641 can be sized and shaped such that an outer surface of the seal member 641 forms a substantially fluid-tight seal with an inner surface of the dial 645 that defines at least a portion of the interior space 646. As shown in FIG. 31 , the seal member 641 defines a first flow passage 642 and a second flow passage 644. When the seal member 641 is in its first position within the interior space 646, the flow passage 642 establishes fluid communication between the inlet port 621 and the first outlet port 647 while fluidly isolating the inlet port 621 from the second outlet port 648. Similarly, when the seal member 641 is in its second position within the interior space 646, the second flow passage 644 establishes fluid communication between the inlet port 621 and the second outlet port 648 while fluidly isolating the inlet port 621 from the first outlet port 647. The collection device 600 operates in a similar manner when the dial 645 is rotated within the distribution member 629 to the second, third and fourth positions. Thus, when the inlet port 621 is positioned to be fluidly connected to a patient (e.g., via a medical device coupled to the inlet port 621 and / or the adapter 604), the first outlet port 630, the second outlet port 631, the third outlet port 632, the fourth outlet port 633 and the fifth outlet port 634 of the distribution member 629 can be selectively positioned to be fluidly connected to the inlet port 621 to allow bodily fluid to flow into the pre-sample reservoir 670, the first sample reservoir 680, the second sample reservoir 680', the third sample reservoir 690 and the fourth sample reservoir 690', respectively.
[0089]
[1142] In operation, the collection device 600 can be used to collect bodily fluids (e.g., blood, plasma, urine, etc.) from a patient with reduced contamination. For example, the inlet port 621 of the collection device 600 can be fluidly coupled to a needle or other lumen-defining device (e.g., flexible sterile tubing). Following venipuncture (or other method of accessing bodily fluids), the seal member can be actuated (or rotated) to its first position, as shown in FIG. 32. Alternatively, the seal member 641 can be preset to the first position, and the collection device 600 can be sealed in other manners to maintain the sterility of the collection device 600. When the seal member 641 is in its first position, the flow controller 640 establishes fluid communication between the inlet port 621 and the first outlet port 630 of the distribution member 629 while fluidly isolating the inlet port 621 from the coupling members 637a, 637b, 637c, and 637d. Thus, as shown by arrow II in FIG. 32, bodily fluid can be transported from the patient through the inlet port 621, the first flow path 642, the first outlet port 647 of the dial 645, the first outlet port 630 of the distribution member 629 and into the pre-sample reservoir 670 in a manner similar to that described above with respect to the collection device 400.
[0090]
[1143] Following collection of the bodily fluid pre-sample in the pre-sample reservoir 670, the seal member 641 can be actuated (rotated) from its first position to its second position relative to the dial 645. Similarly, as shown in FIG. 33, the dial 645 can be actuated (or rotated) until it reaches its second position relative to the distribution member 629. When the seal member 641 and dial 645 are in their second position, the flow controller 640 is disposed in a second configuration and the second flow path 644 of the seal member 641 establishes fluid communication between the inlet port 621 and the flow path 638a of the first coupling member 637a while fluidly isolating the pre-sample reservoir 670 from the inlet port 621. With the flow controller 640 in its second configuration, the sample reservoir 680 can be actuated (e.g., by pushing the piercing member 655a) by a user from its first configuration to its second configuration to establish fluid communication between a portion of the patient's body (e.g., a vein) and the first sample reservoir 680. As described in detail above, moving the sample reservoir 680 to the second configuration causes the piercing member 655a to pierce the vacuum seal of the sample reservoir 680 and be positioned inside the sample reservoir 680. In this second configuration, the portion of the patient's body (e.g., a vein) is exposed to a vacuum suction force from the sample reservoir 680 due to the negative pressure condition (vacuum) within the sample reservoir 680. Thus, bodily fluid can be forced to flow from the portion of the patient's body through the inlet port 621, the second flow path 644, the second outlet port 631, and the flow path 638a and the piercing member 655a of the first coupling member 637a into the first sample reservoir 680, as shown by arrows JJ in FIG.
[0091]
[1144] Once a desired volume (e.g., a second amount) of bodily fluid has been collected in sample reservoir 680, a user can actuate (rotate) flow controller 640 to a third position and / or move sample reservoir 680 back to its first configuration to isolate first sample reservoir 680 from second flow path 644. Once sample reservoir 680 is returned to the first configuration, piercing member 655a is removed from sample reservoir 680 and a seal (e.g., a self-sealing membrane) of sample reservoir 680 fluidly isolates first sample reservoir 680 from flow path 635a. Filling of the other sample reservoirs is similarly performed with flow controller 640 disposed in the third, fourth and fifth configurations, respectively.
[0092]
[1145] 34-40 show a collection device 700 according to an embodiment. The collection device 700 includes a flow diverter mechanism 720, a flow controller 740, and sample reservoirs 780 and 790 (though there are holders for four sample reservoirs, only two sample reservoirs are included in the figures for clarity, and additional sample reservoirs (e.g., fifth, sixth, etc.) can be included as part of the collection device 700). As described further herein, the collection device 700 can be moved between a first configuration, a second configuration, a third configuration, a fourth configuration, and a fifth configuration to deliver a flow of bodily fluid that is substantially free of extracorporeal microorganisms, such as microorganisms present on the skin and / or other undesirable extraneous contaminants. The collection device 700 can be of any suitable shape, size, or configuration. For example, aspects and / or portions of the collection device 700 can be substantially similar in form and / or function to corresponding aspects and / or portions of any of the collection devices 100, 200, 300, 400, 500, and / or 600 described above. Accordingly, such similar aspects and / or portions will not be described in further detail herein. By way of example, in some embodiments, sample reservoirs 780 and 790 of collection device 700 may be substantially similar and / or identical in form and function to sample reservoirs 480 and 490, respectively, included in collection device 400 of Figures 16-22.
[0093]
[1146] The flow splitting mechanism 720 includes a housing 701, a distribution member 729, and a base plate 771. As described above with respect to the collection device 400, the housing 701 defines a first outlet opening 703a, a second outlet opening 703b, a third outlet opening 703c, a fourth outlet opening 703d, and a fifth outlet opening 703e, each configured to be in fluid communication with a different portion of the distribution member 729. More specifically, the distribution member 729 defines and / or forms at least a portion of the pre-sample reservoir 770 in fluid communication with the first outlet opening 703a, a first fluid chamber 735a in fluid communication with the second outlet opening 703b, a second fluid chamber 735b in fluid communication with the third outlet opening 703b, a third fluid chamber 735c in fluid communication with the fourth outlet opening 703d, and a fourth fluid chamber 735d in fluid communication with the fifth outlet opening 703e. Additionally, the housing 701 defines a recess 766 configured to movably receive at least a portion of the flow controller 740, as described further herein.
[0094]
[1147] As shown in FIG. 36, the distribution member 729 defines a chamber or space that forms at least a portion of a pre-sample reservoir 770. The pre-sample reservoir 770 is configured to contain a bodily fluid, such as, for example, blood, plasma, urine, etc. The first outlet opening 703a of the housing 701 can be substantially aligned with an open portion of the pre-sample reservoir 770 such that the pre-sample reservoir 770 can receive a flow of bodily fluid from a patient, as described in detail above. More specifically, the distribution member 729 includes a set of walls 736 that can, for example, divide the interior space of the distribution member 729 into portions and / or spaces that are fluidly isolated from one another. For example, as shown in FIG. 36, the set of walls 736 can divide the interior space of the distribution member 729 into the pre-sample reservoir 770, a first fluid chamber 735a, a second fluid chamber 735b, a third fluid chamber 735c, and a fourth fluid chamber 735d. In some embodiments, wall 736 can equally define and / or form pre-sample reservoir 770 and fluid chambers 735a-735d. In other embodiments, pre-sample reservoir 770 can define a space that is different than the space defined by fluid chambers 735a-735d.
[0095]
[1148] The distribution member 729 further includes a first piercing member 755a, a second piercing member 755b, a third piercing member 755c, and a fourth piercing member 755d in fluid communication with the first fluid chamber 735a, the second fluid chamber 735b, the third fluid chamber 735c, and the fourth fluid chamber 735d, respectively. The piercing members 755a-d can thus be used to pierce the sample reservoirs 780 and 790 (and corresponding sample reservoirs not shown in Figures 34-40) as described in further detail herein, thereby initiating the flow of bodily fluid.
[0096]
[1149] The flow controller 740 of the collection device 700 includes a dial 745 and a seal member 741. The seal member 741 is disposed within a recess 766 of the housing 701 (see, for example, FIGS. 38 and 40). More specifically, the flow controller 740 can be coupled to the housing 701 such that the seal member 741 is disposed between and in contact with a surface of the housing 701 that defines the recess 766 and a surface of the dial 745. The seal member 741 can be configured to form a substantially fluid-tight seal with a surface of the dial 745 and a surface of the housing 701 that defines the recess 766, as described in detail above. As shown in FIG. 35, the seal member 741 defines a first opening 744a, a second opening 744b, a third opening 744c, a fourth opening 744d, and a fifth opening 744e. The arrangement of the sealing member 741 is such that when the sealing member 741 is positioned within the recess 766, the first opening 744a, the second opening 744b, the third opening 744c, the fourth opening 744d and the fifth opening 744e are substantially aligned with the first outlet opening 703a, the second outlet opening 703b, the third outlet opening 703c, the fourth outlet opening 703d and the fifth outlet opening 703e, respectively, of the housing 701.
[0097]
[1150] A dial 745 of the flow controller 740 is rotatably coupled to the housing 701 and is movable relative to the housing 701 between a first position, a second position, a third position, a fourth position, and a fifth position. The dial 745 includes an inlet port 721 that can be fluidly coupled (directly or indirectly via an adapter 704) to a medical device that defines a fluid flow path for drawing and / or transporting bodily fluid from a patient to the collection device 700. As such, the inlet port 721 can be configured to selectively place the pre-sample reservoir 770, the first sample reservoir 780, the second sample reservoir 780', the third sample reservoir 790, and the fourth sample reservoir 790' in fluid communication with the patient, as described in further detail herein. When the dial 745 is in the first position, the flow controller 740 is disposed in a first configuration such that the inlet port 721 may be substantially aligned with the first opening 744a of the seal member 741 and the first outlet opening 703a of the housing 701. In this manner, the first opening 744a of the seal member 741 fluidly isolates the inlet port 721 from the outlet openings 703b, 703c, 703d, and 703e, thereby establishing fluid communication between the inlet port 721 and the first outlet opening 703a while fluidly isolating the inlet port 721 from the fluid chambers 735a-d. When the dial 745 is turned (or actuated) to the second position, the flow controller 740 is placed in a second configuration and the second outlet opening 744b establishes fluid communication between the inlet port 721 and the second outlet opening 703b while fluidly isolating the inlet port 721 from the pre-sample reservoir 770 and the fluid chambers 735b-735d. The collection device 700 operates in a similar manner when the dial 745 is turned to the third, fourth and fifth positions.Thus, when the inlet port 721 is positioned in fluid communication with a patient (e.g., via a medical device coupled to the inlet port 721), the first outlet opening 703a, the second outlet opening 703b, the third outlet opening 703c, the fourth outlet opening 703d and the fifth outlet opening 703e can be selectively positioned in fluid communication with the inlet port 721 so that all of the bodily fluid can flow into the pre-sample reservoir 770, the first sample reservoir 780 or the second sample reservoir 790 (or any other fluid reservoir coupled thereto).
[0098]
[1151] In some embodiments, the housing 701 can selectively limit movement of the dial 745 from its first position to its second, third, fourth, and fifth positions. In some other embodiments, the housing 701 can be configured to prevent movement of the dial once it has been moved to the fifth position. In other words, the housing 701 can include a locking mechanism that prevents the dial 745 from moving from the fifth position back to the first position. This feature can reduce the risk of the bodily fluid collected in the flow chambers 735a-735d and / or sample reservoirs 780 and 790 becoming contaminated from the bodily fluid contained in the pre-sample reservoir 770 (which is at high risk of containing surface-bound microorganisms and / or other undesirable external contaminants). This locking mechanism can also protect medical personnel from exposure to blood-borne pathogens in patient samples, which may include HIV, Hepatitis C, etc. Dial 745 and / or housing 701 may also include mechanical detents and / or other indicators that provide visual or tactile feedback to ensure correct alignment of dial 745 relative to exit port 703a and exit openings 703a-703d in housing 701.
[0099]
[1152] Similar to the embodiment of collection device 400 shown in FIGS. 16-22, collection device 700 includes a pre-sample reservoir 770, which is a chamber contained within distribution member 729. Pre-sample reservoir 770 can contain a bodily fluid, such as, for example, blood, plasma, urine, etc. Pre-sample reservoir 770 is configured to be fluidly coupled to a first outlet port 703a of collection device 700 (located within housing 701). During operation of collection device 700, when flow controller 740 is in the first position, bodily fluid is drawn from a portion of the patient's body (e.g., a vein) through inlet port 721, into pre-sample reservoir 770, an opening for pre-sample reservoir 744a located within seal member 741, and into first outlet port 703a. The pre-sample reservoir 770 is configured to contain a first amount of fluid to be drawn from a patient, where the first amount of bodily fluid can be a predetermined amount or an unquantified amount, such that the first amount of bodily fluid is fluidly isolated from a second amount and / or a third amount and / or a fourth amount and / or a fifth amount of bodily fluid that is later drawn from the patient.
[0100]
[1153] In operation, the collection device 700 can be used to collect bodily fluids (e.g., blood, plasma, urine, etc.) from a patient with reduced contamination. For example, the inlet port 721 of the collection device 700 can be fluidly coupled to a needle or other lumen-defining device (e.g., flexible sterile tubing). Following venipuncture, the dial 745 is turned until it reaches a first position, as shown in FIGS. 37 and 38. Alternatively, the dial 745 can be preset at the first position, as described above, and the collection device 700 can be otherwise sealed to maintain the sterility of the collection device 700. With the dial 745 in the first position, the flow controller 740 is placed in a first configuration, and the first outlet opening 744a of the seal member 741 establishes fluid communication between the inlet port 721 (contained within the housing 701) and the first outlet port 741 while fluidly isolating the inlet port 721 from the four sample flow paths 735a-d. In this first configuration, bodily fluid flows from the portion of the patient's body through the inlet port 721, the first outlet opening 744a of the seal member 741, the first outlet port 703a of the housing 701, and into a pre-sample reservoir 770 defined by the distribution member 770, as shown in Figure 38 by the arrows KK. Thus, a first amount of bodily fluid (predetermined or undetermined) can be received in the pre-sample reservoir 770 immediately following venipuncture and isolated from subsequent samples, as described in detail above.
[0101]
[1154] Following collection of the bodily fluid pre-sample in the pre-sample reservoir 770, the dial 745 can be actuated (or rotated) until it reaches a second position as shown in FIGS. 39 and 40. When the dial 745 is in the second position, the flow controller 740 is placed in a second configuration and the second outlet opening 744a of the seal member 741 establishes fluid communication between the inlet port 721 and the first fluid chamber 735a while fluidly isolating the pre-sample reservoir 770 from the inlet port 721. Once the first fluid chamber 735a is filled with bodily fluid, the flow controller 740 can be moved to a third position to isolate and seal the first flow path 735a from the external environment. Additionally, the sample reservoir 780 can be actuated from the first configuration to the second configuration to transfer bodily fluid from the first fluid chamber 735a to the sample reservoir 780. For example, the sample reservoir 780 can be actuated (pushing the piercing member 755a) from the first configuration to the second configuration, either by a user or automatically, to establish fluid communication between a portion of the patient's body (e.g., a vein) and the sample reservoir 780. As described above, by moving the sample reservoir 780 to the second configuration, the piercing member 755a pierces the vacuum seal of the sample reservoir 780 and is positioned inside the sample reservoir 780. In the second configuration, the portion of the patient's body (e.g., a vein) is exposed to a vacuum suction from the sample reservoir 780 due to a negative pressure condition (vacuum) that exists inside the sample reservoir 780 in some embodiments. Thus, as shown by the arrow LL in FIG. 40, bodily fluid flows from the portion of the patient's body through the inlet port 721, the second outlet opening 744b of the seal member 741, the second outlet opening 703b of the housing 701, the second fluid chamber 735b, and into the first sample reservoir 780.
[0102]
[1155] Once a desired amount (e.g., a second amount) of bodily fluid has been collected in the sample reservoir 780, the user can actuate (rotate) the flow controller 740 to a third position and / or move the sample reservoir 780 back to its first configuration to isolate the first sample reservoir 780 from the inlet port 721. When the sample reservoir 780 returns to the first configuration, the piercing member 755a is removed from the sample reservoir 780 and a seal (e.g., a self-sealing membrane) of the sample reservoir 780 fluidly isolates the first sample reservoir 780 from the second fluid chamber 735b and the external environment. Filling of the other sample reservoirs is performed in the same manner with the flow controller 740 in the third, fourth and fifth configurations, respectively.
[0103]
[1156] In some embodiments, the collection device 700 can be configured such that there is not a set of walls 736 separating different fluid chambers 735a-735d within the distribution member 729 (see detailed cross-section in FIG. 16). In such embodiments, the distribution member 729 is divided between the pre-sample reservoirs 770 and the associated fluid chambers 735 (i.e., the fluid chambers are not separated into four separate portions by walls 736). In such embodiments, a user can fill all four sample reservoirs at once by actuating (rotating) the dial 745 to either the second, third, fourth or fifth position.
[0104]
[1157] Any of the embodiments described herein may be used with a metering device that may be used to meter (e.g., quantify) the flow of bodily fluid into, for example, a pre-sample reservoir and / or a sample reservoir. In some cases, testing standard practices do not ensure consistent compliance with an accurate inoculation volume of bodily fluid (e.g., blood sample) due to the fact that the fill volume is visually determined by the clinician and / or phlebotomist and is therefore subject to human error. The volume indicator on the blood collection bottle is difficult to read when held, and the fact that the collection bottle is not held upright during the withdrawal procedure may contribute to an inaccurate volume of bodily fluid sample received from the patient. Insufficient sample volume (e.g., less than the manufacturer's recommendation) may reduce the sensitivity of the culture test and lead to false negative results. Furthermore, as indicated in the briefs and instructions for use for certain types of testing supplies and equipment (e.g., blood culture bottles designed for use with automated microbial detection systems produced by manufacturers such as Becton Dickinson of Franklin Lakes, NJ), fill volumes greater than the manufacturer's recommendation may result in false positives. Thus, the flow metering and volume display features allow a lab technician and / or medical personnel (e.g., a phlebotomist) to ascertain the volume of bodily fluid that will be collected in each individual sample reservoir prior to placing the sample reservoir in an incubator or other laboratory testing equipment, depending on how the sample needs to be processed. The lab technician and / or phlebotomist can also record accurate volume information (e.g., in a medical record, database, spreadsheet, etc.) for evaluation by a clinician when results are received, thereby helping to reduce the likelihood of misinterpretation of false negative and / or false positive results.
[0105]
[1158] By way of example, Figures 41-45 show a collection device 800 that may include one or more metering devices. The collection device 800 includes a flow diverter mechanism 820, a flow controller 840, a display 875, and a sample reservoir 880. As described further herein, the collection device 800 may be moved between a first configuration, a second configuration, and a third configuration to deliver a flow of bodily fluid that is substantially free of extracorporeal microorganisms, such as microorganisms present on the skin and / or other undesirable extraneous contaminants. The collection device 800 may be of any suitable shape, size, or configuration. For example, aspects and / or portions of the collection device 600 may be substantially similar in form and / or function to corresponding aspects and / or portions of any of the collection devices 100, 200, 300, 400, 500, 600, and / or 700 described above. Accordingly, such similar aspects and / or portions will not be described in further detail herein. By way of example, in some embodiments, the sample reservoir 880 of the collection device 800 may be substantially similar and / or identical in form and function to the sample reservoir 480 included in the collection device 400 of FIGS.
[0106]
[1159] As shown in FIGS. 41-43, the flow diverter mechanism 820 includes an actuator portion 822 (e.g., a first portion), an intermediate portion 823 (e.g., a second portion), and a coupling portion 824 (e.g., a third portion). The actuator portion 822 of the flow diverter mechanism 820 is substantially cylindrical including a pair of actuator walls that define an interior space 806. More specifically, the actuator portion 822 includes a first end that is substantially closed and a second end opposite the first end that is substantially open to allow access to the interior space 806. As such, the actuator portion 822 can movably receive at least a portion of a flow controller 840, as described in further detail herein. The actuator portion 822 further includes an inlet port 821 and an outlet port 831. The inlet port 821 can be fluidly coupled (directly or indirectly via an adapter 804) to a medical device that defines a fluid flow pathway for withdrawing and / or transporting bodily fluid from a patient to the collection device 800, as described in further detail above.
[0107]
[1160] The outlet port 831 of the actuator portion 822 can be selectively positioned to fluidly connect a portion of the interior space 806 of the actuator portion 822 to the interior space 807 defined by the intermediate portion 823. As shown in FIG. 43, the intermediate portion 823 is positioned between the actuator portion 822 and the coupling portion 824. Although not shown in FIGS. 41-45, the intermediate portion 823 can include a metering device that can be configured to, for example, meter a volume of bodily fluid transferred to the sample reservoir 880. For example, in some embodiments, the flow metering device can be fluidly coupled to the outlet port 831 to meter the flow of bodily fluid therethrough. As shown in FIGS. 41 and 42, the intermediate portion 823 can include a display 875 that can provide a user with a visual indicator and / or information related to, for example, the volume of bodily fluid that has flowed through the outlet port 831. In other embodiments, the flow metering device can be positioned at any other suitable location within or along the flow diverter mechanism 820.
[0108]
[1161] Coupling portion 824 can be physically and fluidly coupled to intermediate portion 823. For example, in some embodiments, coupling portion 824 can be partially disposed within interior space 807 of intermediate portion 823 and at least temporarily coupled thereto via a friction fit, press fit, snap fit, threaded coupling, adhesive, or the like. Coupling portion 824 is configured to receive a portion of sample reservoir 880, as described in detail above, and includes a piercing member 855 that can be used to pierce a vacuum seal of sample reservoir 880 and thereby initiate the flow of bodily fluid.
[0109]
[1162] The flow controller 840 of the collection device 800 is at least partially disposed within the interior space 806 defined by the actuator portion 822 and is movable between a first configuration, a second configuration, and a third configuration. As shown in FIGS. 42 and 43, the flow controller 840 includes a movable member 850 having a first seal member 861, a second seal member 862, and a third seal member 863, and a biasing member 859 (e.g., a spring, etc.). The seal members 861, 862, and 863 are in contact with an inner surface of the actuator portion 822 that defines the interior space 806. Thus, as described in more detail herein, the seal members 861, 862, and 863 can each form a substantially fluid-tight seal with an inner surface that can divide, for example, the interior space 806 of the actuator portion 822 into fluidically isolated portions.
[0110]
[1163] The movable member 850 is movable between a first position, a second position, and a third position within the interior space 806. The arrangement of the movable member 850 may be such that the seal members 861, 862, and 863 selectively move within the interior space 806 as the movable member 850 moves between its first position, its second position, and its third position. More specifically, the first seal member 861 may move simultaneously with the movable member 850 as the movable member 850 moves between its first position, its second position, and its third position. The second seal member 862 and the third seal member 863 may be fixedly coupled to each other (e.g., disposed at a fixed distance from each other) and slidably disposed around a portion of the movable member 850, thereby allowing the movable member 850 to move from its first position (e.g., see FIG. 43 ) to its second position (e.g., see FIG. 44 ) while the second seal member 862 and the third seal member 863 remain in a substantially fixed position relative to the actuator portion 822. For example, as the movable member 850 moves between its first and second positions, the second seal member 862 and the third seal member 863 can remain in substantially fixed positions such that the inlet port 821 is located on a first side of the second seal member 862 and the outlet port 831 is located on a second side opposite the first side of the second seal member 862. Thus, as described in more detail herein, when the movable member 850 is in its first position ( FIG. 43 ) and its second position ( FIG. 44 ), the inlet port 821 is in fluid communication with a portion of the interior space 806 defined between the first seal member 861 and the second seal member 862, and the outlet port is in fluid communication with a portion of the interior space 806 defined between the second seal member 862 and the third seal member 863.
[0111]
[1164] The arrangement of the flow controller 840 may be such that when the movable member 850 moves from its first position to its second position, the first seal member 861 moves relative to the second seal member 862 and the third seal member 863. The movement of the first seal member 861 relative to the second seal member 862 may expand a space defined therebetween, thereby forming and / or otherwise defining a pre-sample reservoir 870. Furthermore, the seal members 861 and 862 form a substantially fluid-tight seal with an inner surface of the actuator portion 822, such that the pre-sample reservoir 870 defined between the first seal member 861 and the second seal member 862 is fluidly isolated from the remainder of the interior space 806. Thus, when the movable member 850 moves from its first position to its second position, the inlet port 821 may be in fluid communication with the pre-sample reservoir 870. As the movable member 850 moves from its second position (see, e.g., FIG. 44) to its third position (see, e.g., FIG. 45), a portion of the movable member 850 may contact the third seal member 863 to substantially simultaneously move the first seal member 861, the second seal member 862, and the third seal member 863 within the interior space 806. Thus, the second seal member 862 may be moved relative to the inlet port 821 such that both the inlet port 821 and the outlet port 831 are in fluid communication with a portion of the interior space 806 defined between the second seal member 862 and the third seal member 863, as described in more detail herein.
[0112]
[1165] In operation, the collection device 800 can be used to collect bodily fluids (e.g., blood, plasma, urine, etc.) from a patient with reduced contamination. For example, the inlet port 821 of the collection device 800 can be fluidly coupled to a needle or other lumen-defining device (e.g., flexible sterile tubing). With the inlet port 821 coupled to the lumen-defining device, the flow controller 840 can be moved from its first configuration to its second configuration. In this manner, a user can apply a force to move the movable member 850 from its first position to its second position, as shown by arrow MM in FIG. 44 . As described above, the first seal member 861 moves simultaneously with the movable member 850, thereby expanding the space defined between the first seal member 861 and the second seal member 862, thereby forming and / or defining the pre-sample reservoir 870. The first seal member 861 and the second seal member 862 form a substantially fluid-tight seal with an inner surface of the actuator portion 822 that defines the interior space 806, such that an increase in volume between the first seal member 861 and the second seal member 862 creates a negative pressure within the pre-sample reservoir 870. Thus, when fluid communication is established between a portion of a patient's body (e.g., a vein) and the pre-sample reservoir 870 (e.g., via the inlet port 821 in FIG. 44), the negative pressure difference between the pre-sample reservoir 870 and the portion of the patient's body draws bodily fluid into the pre-sample reservoir 870 through the inlet port 821, as shown by arrows NN in FIG. 44. In this first configuration, the flow controller 840 also fluidly isolates the pre-sample reservoir 870 from the outlet port 831. Thus, a first amount (predetermined or unmeasured) of bodily fluid can be received into the pre-sample reservoir 870 immediately after (e.g.) venipuncture and isolated from a subsequent sample. In this manner, collection device 800 can be used to prevent a first volume of bodily fluid that is most likely to contain surface microorganisms and / or other undesirable external contaminants from contaminating subsequent volumes of bodily fluid sample that are collected and used for diagnostic or other tests that may be affected by the contaminants.In some embodiments, the metering device can measure the volume of bodily fluid placed in the pre-sample reservoir 870 and present a value related to that volume on the display 875.
[0113]
[1166] Following collection of the volume of bodily fluid pre-sample in the pre-sample reservoir 870, the movable member 850 may be moved from its second position to its third position to place the flow controller in a third configuration, as indicated by arrow OO in FIG. 45 . As described above, as the movable member 850 moves from its second position to its third position, a portion of the movable member 850 is disposed in contact with the third seal member 863. Thus, the movable member 850 moves the first seal member 861, the second seal member 862, and the third seal member 863 substantially simultaneously within the interior space 806. Thus, the second seal member 862 may be moved relative to the inlet port 821 such that both the inlet port 821 and the outlet port 831 are in fluid communication with a portion of the interior space 806 defined between the second seal member 862 and the third seal member 863. Further, because the volume of bodily fluid is fluidly isolated within pre-sample reservoir 870, movement of second seal member 862 and third seal member 863 in the direction of first seal member 861 is restricted (i.e., the bodily fluid is a substantially incompressible fluid). In this manner, the pre-sample volume of bodily fluid is sequestered within pre-sample reservoir 870, and a space defined between second seal member 862 and third seal member 863 defines a fluid flow path between inlet port 821 and outlet port 831. Further, the arrangement of flow controller 840 is such that, when in its third configuration, first seal member 861 is disposed in contact with biasing member 859, and at least a portion of a force applied by a user to movable member 850 is operable to deform, compress, bend and / or otherwise reconfigure biasing member 859. Thus, the biasing member 859 can exert a counter force on the first seal member 861 resisting movement of the flow controller 840 from its second configuration to its third configuration, as described in more detail herein.
[0114]
[1167] As described in detail above, the sample reservoir 880 can be positioned relative to the collection device 800 such that the piercing member 855 pierces a vacuum seal of the sample reservoir 880 and is positioned inside the sample reservoir. A pressure difference between the sample reservoir 880 (e.g., vacuum or negative pressure) and that part of the body draws bodily fluid into the sample reservoir 880. In other words, in the second configuration, the flow controller 840 and the flow diverter mechanism 820 establish a fluid flow path such that bodily fluid can be drawn from the patient through the inlet port 821, the portion of the interior space 806 defined between the second seal member 862 and the third seal member 863, the outlet port 831 of the actuator portion 822, through the piercing member 855 of the intermediate portion 823 and the coupling portion 824, and into the sample reservoir 880, as shown by arrows PP in FIG. As mentioned above, a metering device (not shown) can, for example, meter the volume of bodily fluid transferred through outlet port 831 and present a value related to the volume of bodily fluid on display 875.
[0115]
[1168] Once a desired volume (e.g., a second amount) of bodily fluid has been collected within the sample reservoir 880, the user can remove and / or reduce the force applied to the movable member 850, causing the biasing member 859 to move the first seal member 861 and the movable member 850 from their third position toward their second position. Furthermore, due to the bodily fluid disposed within the pre-sample reservoir 870 being substantially incompressible, the movement of the first seal member 861 transfers a force through the volume of bodily fluid to move the second seal member 862 and the third seal member 863 from their third position toward their second position. In some embodiments, the biasing member 859 can apply a force to the first seal member 861 that can be operable to move the second seal member 862 relative to the actuator portion 822 to a fourth position that can substantially block, for example, the inlet port 821. Thus, the inlet port 821 can be fluidly isolated from the interior space 806 of the actuator portion 822. Additionally, the piercing member 855 can be removed from the sample reservoir 880 and a seal (e.g., a self-sealing membrane) can fluidly isolate the bodily fluid sample from the space outside the sample reservoir 880. Subsequent filling of the sample reservoir can be similarly performed by placing the piercing member 855 within the sample reservoir and moving the flow controller 840 to the third configuration to allow bodily fluid to flow from the patient into the sample reservoir.
[0116]
[1169] 46-53 show a collection device 900 according to an embodiment. The collection device 900 includes a flow diverter mechanism 920, a flow controller 940, and sample reservoirs 980, 980', 990, and 990'. As described further herein, the collection device 900 can be moved between a first configuration, a second configuration, a third configuration, a fourth configuration, and a fifth configuration to deliver a flow of bodily fluid that is substantially free of extracorporeal microorganisms, such as microorganisms present on the skin and / or other undesirable external contaminants. The collection device 900 can be of any suitable shape, size, or configuration. For example, aspects and / or portions of the collection device 900 can be substantially similar in form and / or function to corresponding aspects and / or portions of any of the collection devices 100, 200, 300, 400, 500, 600, 700, and / or 800 described above. Accordingly, such similar aspects and / or portions will not be described in further detail herein. By way of example, in some embodiments, sample reservoirs 980, 980', 990 and 990' of collection device 900 may be substantially similar and / or identical in form and function to sample reservoirs 680, 680', 690 and 690' included in collection device 600 of Figures 26-33.
[0117]
[1170] The flow diverter mechanism 920 includes a housing 901, a distribution member 929, and movable members 950a, 950b, 950c, and 950d. The housing 901 is physically and fluidly coupled to the distribution member 929 and provides and / or defines a set of fluid flow paths for collecting bodily fluid from the patient. The housing 901 includes a set of displays 975′ (e.g., liquid crystal displays (LCDs), etc.) that may be included and / or otherwise coupled (e.g., electrically and / or mechanically) to a flow metering device, as described in more detail herein. The housing 901 defines a recess 966, outlet openings 903a, 903b, 903c, 903d, 903e, and movable member openings 950a, 950b, 950c, 950d (also referred to herein as “openings”). The recess 966 is configured to receive a seal member 941 included in a flow controller 940, as described in more detail herein. The first outlet opening 903a, the second outlet opening 903b, the third outlet opening 903c, the fourth outlet opening 903d, and the fifth outlet opening 903e are each configured to define a different fluid flow path in fluid communication with a different portion of the distribution member 929. More specifically, the distribution member 929 defines and / or forms at least a portion of the pre-sample reservoir 970 in fluid communication with the first outlet opening 903a, a first flow path 935a in fluid communication with the second outlet opening 903b, a second flow path 935b in fluid communication with the third outlet opening 903b, a third flow path 935c in fluid communication with the fourth outlet opening 903d, and a fourth flow path 935 in fluid communication with the fifth outlet opening 903e.
[0118]
[1171] As shown in Figures 47 and 48, the distribution member 929 defines a chamber or space that defines at least a portion of a pre-sample reservoir 970. The pre-sample reservoir 970 is configured to contain a bodily fluid, such as, for example, blood, plasma, urine, etc. As described in detail above with respect to the pre-sample reservoir 470 in Figures 16-22, the first outlet opening 903a of the housing 901 can be substantially aligned with an open portion of the pre-sample reservoir 970 to allow the pre-sample reservoir 970 to receive a flow of bodily fluid from the patient. The flow channels 935a-935d extend radially from a center of the distribution member 929 and are positioned such that each of the flow channels 935a, 935b, 935c, and 935d is fluidly isolated from the pre-sample reservoir 970 and the other flow channels. In this manner, the flow channels 935a, 935b, 935c, and 935d can be oriented and / or otherwise defined as a fluid flow path between a first end defining an opening substantially aligned with the outlet openings 903b, 903c, 930d, and 903e, respectively, and a second end defining an opening or port configured to receive the movable members 950a, 950b, 950c, and 950d, respectively. Although in Figs. 47 and 48 the distribution member 929 is shown as including the flow channels 935a-935d that are substantially closed, in other embodiments the flow channels 935a-935d can be substantially open, as shown and described above with respect to the distribution member 429 of Figs. 17 and 18. Thus, the distribution member 929 of the collection device 900 can function substantially similarly to the distribution member 429 of the collection device 400.
[0119]
[1172] The movable members 950a, 950b, 950c and 950d are movably disposed in the openings 905a, 905b, 905c and 905d, respectively, of the housing 901 and corresponding openings defined by the second end of the distribution member 929. Although not shown in Figures 46-53, in some embodiments, the movable members 950a, 950b, 950c and 950d can be operably coupled to a biasing member or the like, as described in detail above with respect to the movable members 250 and 250' of the collection device 200. In this manner, the movable members 950a, 950b, 950c and 950d can be actuated (moved) by a user from a first position and a second position relative to the housing 901 and the distribution member 929 to direct a fluid flow into the first sample reservoir 980, the second fluid reservoir 980', the third fluid reservoir 990 and the fourth sample reservoir 990', respectively. The movable members 950a, 950b, 950c, and 950d are substantially the same and therefore will be described in FIG. 49 with respect to a single movable member 950. Additionally, some portions of the movable member 950 may be substantially similar to the movable members 250 and 350 described above. Thus, some portions of the movable member 950 will not be described in further detail herein. The movable member 950 defines an internal cavity 952 in fluid communication with an inlet port 953 and a piercing member 955. The piercing member is substantially similar to that described in detail above. The inlet port 953 extends through a set of walls that define the internal chamber 952 to selectively position the interior space 952 of the movable member 950 in fluid communication with the corresponding flow passage 935a, 935b, 935c, or 935d.
[0120]
[1173] As shown in FIG. 49, the movable member 950 includes a flow control mechanism 967 rotatably disposed within the interior space 952 and in substantially direct fluid communication with the inlet port 953. The flow metering mechanism 967 may be, for example, a wheel that may include a set of spokes or fins, or the like. In this manner, bodily fluid may enter the inlet port 953 of the movable member 950 and flow through the flow metering device 967, which may cause the flow metering device 967 to rotate relative to the movable member 950. Thus, the rotational characteristics of the flow metering device 967 may be usable in determining the volume, volumetric flow rate, etc. of bodily fluid transferred to the interior space 952 of the movable member 950. Although not shown in FIGS. 46-53, the flow control mechanism 967 of the movable member 950 is operably coupled to a display 975′ of the housing 901. Thus, volumetric information related to the flow of bodily fluid can be presented on the displays 975' as the bodily fluid is transferred, for example, to the sample reservoirs 980, 980', 990 and / or 990'. In this manner, a user can operate the collection device 900 to collect a bodily fluid sample from a patient and visualize at least one of the displays 975' to determine, for example, an accurate volume of the bodily fluid sample that is transferred to the sample reservoir 980.
[0121]
[1174] The flow controller 940 of the collection device 900 includes a dial 945 and a seal member 941. The seal member 941 is disposed within a recess 966 of the housing 901. More specifically, the flow controller 940 can be coupled to the housing 901 such that the seal member 941 is disposed between and in contact with a surface of the housing 901 that defines the recess 966 and a surface of the dial 945. As described in detail herein, the seal member 941 can be configured to form a substantially fluid-tight seal with a surface of the dial 945 and a surface of the housing 901 that defines the recess 966. As shown in FIG. 47, the seal member 941 defines a first opening 944a, a second opening 944b, a third opening 944c, a fourth opening 944d, and a fifth opening 944e. The positioning of the sealing member 941 is such that when the sealing member 941 is positioned within the recess 966, the first opening 944a, the second opening 944b, the third opening 944c, the fourth opening 944d and the fifth opening 944e are substantially aligned with the first outlet opening 903a, the second outlet opening 903b, the third outlet opening 903c, the fourth outlet opening 903d and the fifth outlet opening 903e, respectively, of the housing 901.
[0122]
[1175] A dial 945 of the flow controller 940 is rotatably coupled to the housing 901 and is movable relative to the housing 901 between a first position, a second position, a third position, a fourth position, and a fifth position. The dial 945 includes an inlet port 921 that can be fluidly coupled (directly or indirectly via an adapter 904) to a medical device that defines a fluid flow path for drawing and / or transporting bodily fluid from a patient to the collection device 900. As such, the inlet port 921 can be configured to selectively place the pre-sample reservoir 970, the first sample reservoir 980, the second sample reservoir 980', the third sample reservoir 990, and the fourth sample reservoir 990' in fluid communication with the patient, as described in further detail herein. The dial 945 can be configured to rotate through a first position, a second position, a third position, a fourth position and a fifth position in a manner substantially similar to that described above with respect to the dial 445 of the collection device 400, and therefore will not be described in further detail herein.
[0123]
[1176] As shown, the dial 945 can further include a display 975 that can be configured to present volumetric information related to the flow of bodily fluid. For example, although not shown in FIGS. 46-53 , the dial can include a flow metering device, such as flow metering device 967 included on the movable member 950. In this manner, the flow metering device can meter the flow of bodily fluid, for example, through the inlet port 921, and can be operably coupled to the display 975 such that volumetric information related to the flow of bodily fluid through the inlet port 921 is presented on the display 975 of the dial 945.
[0124]
[1177] In operation, the collection device 900 can be used to collect bodily fluids (e.g., blood, plasma, urine, etc.) from a patient with reduced contamination. For example, the inlet port 921 of the collection device 900 can be fluidly coupled to a needle or other lumen-defining device (e.g., flexible sterile tubing). Following venipuncture (or other method of accessing bodily fluids), the dial 945 is actuated (or turned) until it reaches a first position, as shown in FIGS. 50 and 51 . Alternatively, the dial 945 can be preset to the first position, and the collection device 900 can be otherwise sealed to maintain the sterility of the collection device 900.
[0125]
[1178] As described above, when the dial 945 is in the first position, the flow controller 940 is placed in a first configuration, and the first opening 944a of the seal member 941 establishes fluid communication between the inlet port 921 and the first outlet port 930 (contained within the housing 901) while fluidly isolating the inlet port 921 from the four flow paths 935a-d. Additionally, the sample reservoirs 980, 980', 990 and 990' are fluidly isolated from the inlet port 921 in the first configuration, defining a fluid flow path between a portion of the patient's body (e.g., a vein) and the pre-sample reservoir 970, as shown by the arrows QQ in FIG. 51. In this first configuration, bodily fluid flows (e.g., by gravity, vacuum, etc.) from that portion of the patient's body through the inlet port 921, the first opening 944a of the seal member 941, the first outlet port 903a of the housing 901, and into the pre-sample reservoir 970. In the first configuration, the flow controller 940 also fluidically isolates the pre-sample reservoir 970 from the flow paths 935a-935d. Thus, a first amount (predetermined or undetermined) of bodily fluid can be received in the pre-sample reservoir 970 immediately after venipuncture and isolated from subsequent samples. In this manner, the collection device 900 can be used to ensure that a first amount of bodily fluid that is most likely to contain surface microorganisms and / or other undesirable contaminants does not contaminate subsequent amounts of bodily fluid samples that are collected and used for diagnosis or other tests that may be affected by the contaminants. Additionally, the display 975 can present information received from a flow control mechanism (not shown), for example, related to the volume of bodily fluid transferred to the pre-sample reservoir 970. Thus, a precise volume of bodily fluid can be transferred to and fluidically isolated within the pre-sample reservoir.
[0126]
[1179] Following collection of the bodily fluid pre-sample in the pre-sample reservoir 970, the dial 945 can be actuated (or rotated) until it reaches a second position, as shown in Figures 52 and 53. When the dial 945 is in the second position, the flow controller 940 is placed in the second configuration and the second opening 944b of the seal member 941 establishes fluid communication between the inlet port 921 and the flow path 935a while fluidly isolating the pre-sample reservoir 970 from the inlet port 921. With the flow controller 940 in the second configuration, the movable member 950a can be actuated (i.e., depressed) by a user from the first position to the second position to establish fluid communication between the patient (e.g., a vein) and the first sample reservoir 880. More specifically, as shown by arrow RR in FIG. 53, the movable member 950 moves from its first position to its second position such that the piercing member 955 passes through the vacuum seal of the first sample reservoir 980 and is positioned within the first sample reservoir 980.
[0127]
[1180] While in the second position, the inlet port 953 of the movable member 950 is substantially aligned and in fluid communication with the first flow path 935a, thereby allowing bodily fluid to flow from the first flow path 935a into the internal cavity 952 of the movable member 950 and out of the piercing member 955 into the first sample reservoir 980. A pressure difference between the sample reservoir 980 (e.g., vacuum or negative pressure) and the first flow path 935a draws bodily fluid into the sample reservoir 980. In other words, in the second configuration, the flow controller 940 and the movable member 950a establish a fluid flow path between the inlet port 921 of the dial 945 and the first sample reservoir 980, as shown by the arrows SS in FIG. 53. Additionally, the flow of bodily fluid through the movable member 950a causes the flow metering mechanism 967 to rotate relative to the movable member 950. Thus, rotation of the flow metering mechanism 967 may be usable in determining the volume of the bodily fluid sample transferred to the sample reservoir 980. Additionally, the display 975' may present information received from the flow control mechanism 967, for example, related to the volume of bodily fluid transferred to the sample reservoir 980. Thus, an accurate volume of bodily fluid may be transferred to the sample reservoir 980. For example, in some cases, the collection device 900 may be used to collect three sample volumes of 20 mL in each of the first sample reservoir 980, the second sample reservoir 980', and the third sample reservoir 990 (i.e., a total sample volume of 60 mL is collected).
[0128]
[1181] Once a desired volume (e.g., a second amount) of bodily fluid has been collected in the first sample reservoir 980, the user can release the movable member 950 to allow the biasing member (not shown) to move back to its first position. When the movable member 950 returns to its first position, the piercing member 955 is removed from the first sample reservoir 980 and a seal (e.g., a self-sealing membrane) fluidly isolates the first sample reservoir 980 from the internal flow path 935. The collection device 900 can be used to similarly transfer a second sample volume to the second sample reservoir 980', a third sample volume to the third sample reservoir 990, and a fourth sample volume to the fourth sample reservoir 990' by rotating the dial 945 to its third, fourth, and fifth positions, respectively.
[0129]
[1182] In some cases, the fluid collection device 900 allows a clinician and / or phlebotomist to open a package containing the fluid collection device 900, remove only the housing 901 (including the dispensing member 929), and take the housing 901 to the patient's bedside. The clinician and / or phlebotomist can perform venipuncture on a part of the patient's body (e.g., a vein) using any standardized technique (or employ any other method of accessing the patient's fluids). Following venipuncture, the clinician and / or phlebotomist can collect the total blood volume required for all samples. For example, the clinician and / or phlebotomist can collect a 2.5 mL pre-sample dispense volume and a 10 mL sample volume for each of the four sample reservoirs, resulting in a total of 42.5 mL of collected fluid (e.g., blood). Following collection of the desired amount of bodily fluid, the hypodermic needle can be removed from that portion of the patient's body (e.g., a vein) and the clinician and / or phlebotomist can place the housing 901 (containing the bodily fluid) over a 4-pack (or 2-pack) of pre-sterilized sample reservoirs with the membrane tops pre-placed in a custom tray that matches the shape of the housing 901. By using such a pre-sterilized pack of sample reservoirs, the clinician does not need to perform a process step of "wiping" the tops of the sample reservoirs with a sterilant, thereby reducing the possibility of contamination, for example, if the reservoir tops are improperly and / or insufficiently sterilized. The clinician and / or phlebotomist can then initiate automated inoculation of the sample reservoirs with bodily fluid with precise volumetric control. In some embodiments, after inoculation of the sample reservoirs is complete, the entire device 900, with volumetric information displayed for each individual sample reservoir, can be sent to a laboratory for analysis. In other embodiments, sample reservoirs 980 and / or 990 can be individually removed and sent to a laboratory for analysis.
[0130]
[1183] Although the collection device 900 has been shown and described with reference to Figures 46-53 as including a set of displays 975 and 975' capable of presenting volumetric data regarding the volume of bodily fluid transferred through a portion of the collection device, in other embodiments, the collection device may include any suitable flow metering mechanism having any suitable output indicator. For example, Figures 54 and 55 show a flow diverter mechanism 1020 and a flow controller 1040 according to an embodiment. The flow diverter mechanism 1020 and the flow controller 1040 may be substantially similar in form and function to the flow diverter mechanism 920 and the flow controller 940, respectively. Thus, similar parts will not be described further herein. However, the flow diverter mechanism 1020 and the flow controller 1040 may differ in the arrangement of the set of displays 1075. For example, the flow diverter mechanism 1020 includes a housing 1001 configured to movably receive a set of movable members 1050a, 1050b, 1050c, and 1050d, each of which may include a flow metering mechanism, as described above with respect to the movable member 950. The movable members 1050a, 1050b, 1050c, and 1050d may then be used to determine an accurate volume of bodily fluid transferred therethrough. As shown in FIG. 55, the display 1075 of the housing 1001 may include a set of three lights, including a first light associated with a small volume (e.g., 5 mL), a second light associated with a medium volume (e.g., 20 mL), and a third light associated with an acceptable and / or large volume (e.g., 40 mL). In this manner, as the flow of bodily fluid is transferred through the flow controller 1040 and the flow diverter mechanism 1020, for example into the first movable member 1050a, the flow metering mechanism contained therein can send a signal or the like to a display, which is operable to illuminate the first light, the second light and / or the third light according to the volume of bodily fluid transferred through the movable member 1050.
[0131]
[1184] In other embodiments, the movable members 1050a, 1050b, 1050c, and 1050d can be moved from a first position to a second position, a third position, or a fourth position relative to the housing 1001. In such embodiments, the positions can be associated with, for example, an intended volume of bodily fluid to be transferred to the sample reservoir. For example, in some embodiments, a user can actuate (e.g., move) the movable member 1050a from its first position to its second position. In such embodiments, the second position can be associated with, for example, a small volume (e.g., 10 mL) of bodily fluid to be transferred to the sample reservoir. In some embodiments, the housing 1001 and / or the movable member 1050a can include a detent, lock, catch, protrusion, recess, etc. that can temporarily hold the movable member 1050a in the second position until a low volume of sample has been transferred to the sample reservoir. Additionally, when placed in the second position, the display 1075 can be configured to illuminate a first light associated with the small volume to indicate to a user a preset volume of bodily fluid to be transferred to the sample reservoir. Once a desired volume of bodily fluid has been transferred to and fluidly isolated within the sample reservoir, the flow diversion mechanism 1020 can be configured to automatically return the movable member 1050a to its first position. In this manner, the flow diversion mechanism 1020 and flow controller 1040 can be physically and fluidly coupled to any number of sample reservoirs and used to transfer precise volumes of bodily fluid to each sample reservoir.
[0132]
[1185] FIG. 56 is a flow chart illustrating a method 1190 of obtaining a predetermined sample volume of bodily fluid from a patient using a flow metering transfer device. The flow metering transfer device can be any of the transfer devices described herein (also referred to herein as a "collection device"). By way of example, in some embodiments, the transfer device can be the collection device 900 described above with reference to FIGS. 46-53. Thus, the transfer device can include an inlet port configured to be selectively positioned in fluid communication with a patient, a pre-sample reservoir and a sample reservoir, and a flow metering mechanism configured to meter the flow of bodily fluid from the patient to the pre-sample reservoir and the flow of bodily fluid to the sample reservoir. The method 1190 includes, at 1191, establishing fluid communication between the patient and a port of the flow metering transfer device. For example, the port can be fluidly coupled to a needle or other lumen defining device (e.g., flexible sterile tubing), and the needle or other lumen defining device can be inserted into the patient's body (e.g., via a venipuncture event or other method of accessing bodily fluid).
[0133]
[1186] With the port in fluid communication with the patient, at 1192, fluid communication between the port and the pre-sample reservoir is established. In some embodiments, the flow metering transfer device can include a flow controller or the like (e.g., flow controller 940 included in the collection device 900) that can be actuated and / or manipulated (e.g., rotated) to a position (e.g., a first position) that establishes fluid communication between the port and the pre-sample reservoir. In some embodiments, actuation of the flow controller can cause the flow controller and the flow diverter mechanism to collectively define at least a portion of a fluid flow path between the port and the pre-sample reservoir. In some embodiments, the pre-sample reservoir can include a negative pressure or the like that can initiate a flow of bodily fluid from the patient to the pre-sample reservoir. In other embodiments, the flow of bodily fluid can be initiated in any other suitable manner (e.g., gravity, etc.).
[0134]
[1187] At 1193, the flow of bodily fluid transferred from the patient to the pre-sample reservoir is metered. For example, in some embodiments, the port can include a flow control mechanism that can meter the flow of bodily fluid through the port (e.g., in a manner similar to that described above with respect to the flow control mechanism 967 of the collection device 900). Thus, a pre-sample volume of bodily fluid is transferred to the pre-sample reservoir. The method 1190 includes, at 1194, verifying via the flow metering mechanism of the flow metering transfer device that the pre-sample volume of bodily fluid placed in the pre-sample reservoir is a predetermined pre-sample volume of bodily fluid. For example, the flow metering mechanism can include and / or be operably coupled to a display or the like (e.g., the display 975 and / or 975' of the collection device 900). The flow metering mechanism can be configured to present volume information on a display, as described above.
[0135]
[1188] Once the pre-sample volume of bodily fluid is disposed within the pre-sample reservoir, the pre-sample reservoir is fluidly isolated from the port at 1195 to seal off the pre-sample volume of bodily fluid within the pre-sample reservoir. For example, in some cases, the flow controller and / or the flow diverter mechanism can be actuated (or rotated) from a first position and / or a first configuration to a second position and / or a second configuration. When the flow controller and / or the flow diverter mechanism is in the second configuration, the pre-sample reservoir is fluidly isolated from a space external to the pre-sample reservoir. In some embodiments, once the flow controller and / or the flow diverter mechanism is actuated to its second position and / or second configuration, fluid communication is established between the port and the sample reservoir at 1196. For example, in some embodiments, the flow metering transfer device can include a movable member (e.g., movable member 950), or the like, which can include a piercing member configured to pierce a portion of the sample reservoir (e.g., a membrane, etc.). Thus, when the flow controller and / or diverter mechanism is in its second position and / or second configuration, piercing the portion of the sample reservoir places the sample reservoir in fluid communication with the port. As discussed above, the sample reservoir can include, for example, a negative pressure or the like that can initiate a flow of bodily fluid from the patient into the sample reservoir.
[0136]
[1189] At 1197, the flow of bodily fluid transferred from the patient to the pre-sample reservoir is metered. For example, as described above, the port can include a flow control mechanism that can meter the flow of bodily fluid through the port (e.g., in a manner similar to that described above with respect to flow control mechanism 967 of collection device 900). In some embodiments, the flow control mechanism can be included in a movable member, such as, for example, movable member 950 of FIG. 49. Thus, a sample volume of bodily fluid is transferred to the sample reservoir. The method 1190 includes, at 1198, verifying that the sample volume of bodily fluid placed in the sample reservoir is a predetermined sample volume of volume via the flow metering mechanism of the flow metering transfer device. For example, a display or the like can be configured to present the volume information, as described above.
[0137]
[1190] In this manner, a predetermined pre-sample volume of bodily fluid, which may contain, for example, external microorganisms, is collected. For example, in some embodiments, the predetermined pre-sample volume may be about 0.1 mL, about 0.3 mL, about 0.5 mL, about 1.0 mL, about 2.0 mL, about 3.0 mL, about 4.0 mL, about 5.0 mL, about 10 mL, about 20 mL, about 50 mL, and / or any volume or fraction of volume therebetween. In other embodiments, the pre-sample volume may be greater than 50 mL or may be 0.1 mL. In other embodiments, the predetermined pre-sample volume may be between about 2 mL and about 5 mL. In one embodiment, the predetermined pre-sample volume may be about 3 mL. Furthermore, by collecting the predetermined pre-sample volume, the predetermined sample volume disposed in the one or more sample reservoirs may be substantially free of external microorganisms. In some embodiments, the predetermined sample volume may be between 10 mL and 60 mL. In other embodiments, the predetermined sample volume may be between 30 mL and 60 mL. In yet other embodiments, the predetermined sample volume may be 60 mL. Although the sample volume of bodily fluid has been described above as being transferred to a single sample reservoir, in other embodiments, the flow metering transfer device can be used to transfer a predetermined sample volume to two or more sample reservoirs. For example, in some embodiments, a predetermined pre-sample volume of bodily fluid can be collected in and fluidically isolated within a pre-sample reservoir, as described above. With the pre-sample volume fluidically isolated, the flow metering transfer device can be used to transfer a predetermined sample volume to a first sample reservoir, a predetermined sample volume to a second sample reservoir, and a predetermined sample volume to a third sample reservoir. In such a case, the predetermined sample volume can be, for example, 20 mL, such that the total sample volume placed in the first, second, and third reservoirs is 60 mL.
[0138]
[1191] Various embodiments of the fluid collection device described herein may allow for the collection of two (or more) sets of fluid (e.g., blood) samples from a single venipuncture. The current standard of care requires that some tests (e.g., blood cultures) be performed by obtaining samples from separate, independent fluid access points (e.g., via two separate venipunctures, via catheter + venipuncture, and / or a combination thereof). The embodiments described herein may facilitate obtaining multiple samples for a given diagnostic test (e.g., blood culture tests) from a single fluid access point (e.g., venipuncture), thereby reducing the annual number of venipunctures required to obtain these samples by half. This is beneficial for both patients and medical personnel alike. Reducing the number of venipunctures (and / or other blood access procedures) may significantly reduce the risk of needlestick injury to medical personnel and reduce patient-related complications resulting from these procedures (e.g., hematoma, thrombosis, phlebitis, infection, etc.). Additionally, reducing the number of fluid access procedures (e.g., venipuncture) reduces supply utilization, labor, and waste associated with these procedures. The cost savings realized by the healthcare system are significant and represent an opportunity to promote improved patient outcomes due to more efficient resource consumption as well as improved sample integrity resulting in more accurate patient diagnoses that inform the development and implementation of treatment plans. The fluid collection devices also significantly reduce the occurrence of false positives from post-collection analysis. The fluid collection devices described herein can also streamline the fluid collection process, reducing the number of manual steps and "touch points," thereby reducing the opportunity for external contamination. The devices described herein can also minimize the risk of needlestick injury and infection to laboratory technicians and / or phlebotomists.
[0139]
[1192] In some embodiments, the bodily fluid collection devices described herein (e.g., 100, 200, 300, 400, 500, 600, 700, 800, and 900) may include and / or be formed in part from an antiseptic saturated material (e.g., housing 401). Current standards rely on medical personnel to place an individual antiseptic material (e.g., isopropyl alcohol swab) on top of each sample reservoir (e.g., 480, 480', 490, and 490'). To ensure compliance with this protocol, device 400 (for example) may include an antiseptic material disposed within device 400 such that when housing 401 is placed on top of a 4-pack (or 2-pack) of bottles, as shown in FIG. 16, the first point of contact from housing 401 and the top of sample reservoirs 480, 480', 490, 490' is the antiseptic material. In this manner, it is ensured that the tops of the sample reservoirs 480, 480', 490, 490' are properly disinfected before bodily fluid is inoculated into the sample reservoirs.
[0140]
[1193] Although various embodiments have been specifically shown and described, various changes in form and detail may be made. For example, while the dial 445 (actuator) has been shown and described with reference to Figs. 19-22 as rotating in a single direction, in other embodiments, the dial 445 (actuator) may be rotated in a first direction and a second direction opposite the first direction. In such embodiments, rotation in the second direction may be configured to move the collection device through any number of configurations. In other embodiments, rotation of the actuator in the second direction may be limited. In some embodiments, the dial may include a mechanical stop or lock to fluidically isolate the first volume of bodily fluid received from the patient (i.e., the contaminated sample). In other words, once the first reservoir (pre-sample reservoir) is filled with a predetermined volume of bodily fluid and the user rotates the dial (actuator) to begin drawing additional sample, the dial (actuator) cannot be moved back to establish fluid communication with the first sample volume (contained within the pre-sample reservoir).
[0141]
[1194] Although several embodiments have been described above, it should be understood that they are presented merely as examples and not as limitations. Although various embodiments have been described as including certain combinations of features and / or components, other embodiments are possible having any combination or subcombination of any features and / or components from any of the embodiments described herein. For example, while the collection device 700 is shown and described with reference to Figs. 34-40 as having a first, second, third, fourth or fifth configuration, in other embodiments, the collection device described herein can have more or fewer configurations. Furthermore, while the collection device 200 is shown and described with reference to Figs. 2-13 as having a vacuum-assisted collection tube as the pre-sample reservoir 270, in other embodiments, the collection device 200 can have a chamber contained within the housing 201 similar to the collection device 400 of the embodiment presented in Figs. 16-22, including the pre-sample reservoir 470, which is a chamber contained within the distribution member 429, or vice versa.
[0142]
[1195] The specific configuration of the various components may also vary. For example, the size and specific shape of the various components may differ from the illustrated embodiment while still providing functionality as described herein. More specifically, the size and shape of the various components may be specifically selected for a desired flow rate of the bodily fluid flow into the fluid reservoir. For example, although a flow metering mechanism 967 is specifically shown in FIG. 49, any of the collection devices described herein may be used with any suitable flow metering mechanism. For example, in some embodiments, the collection device may include a flow metering mechanism and / or any other mechanism, device or method configured to measure volumetric characteristics of bodily fluids, such as, for example, a pressure sensor, a voltage sensor, an optical sensor, a velocity sensor, a flow meter, a strain gauge, a valve, a turbine, a float, displacement analysis, density analysis, gravimetric analysis, optical analysis, ultrasonic analysis, thermal analysis, Doppler analysis, electromagnetic field (emf) analysis, reflectance analysis, obstruction analysis, area analysis, Venturi analysis, Coriolis analysis, visual analysis, and / or any other suitable sensor, analysis and / or calculation (e.g., applying and / or using Boyle's law, ideal gas law, force calculations (force = mass x acceleration), etc., by way of example only).
Claims
1. 1. An apparatus for obtaining a bodily fluid sample from a patient, comprising: a pre-sample reservoir configured to receive a first volume of bodily fluid drawn from the patient; a flow diversion mechanism including an inlet port, a first outlet port, and a second outlet port, the inlet port configured to be coupled to a lumen-defining device to receive bodily fluid from a patient, the first outlet port configured to fluidly couple the pre-sample reservoir to the flow diversion mechanism, the second outlet port configured to fluidly couple a sample reservoir to the flow diversion mechanism, the flow diversion mechanism defining a first fluid flow path configured to place the first outlet port in fluid communication with the inlet port and a second fluid flow path configured to place the second outlet port in fluid communication with the inlet port; a flow metering mechanism in fluid communication with the first fluid flow path and the second fluid flow path, the flow metering mechanism configured to meter a flow of a first volume of bodily fluid through the first fluid flow path and into the pre-sample reservoir, and to meter a flow of a second volume of bodily fluid through the second fluid flow path and into the sample reservoir, and configured to display a volume indicator associated with the first volume and the second volume.
2. 2. The device of claim 1, wherein a first volume of the bodily fluid flows in the first fluid flow path during a first period of time, and a second volume of the bodily fluid flows in the second fluid flow path during a second period of time after the first period of time.
3. 10. The device of claim 1, wherein the first volume of bodily fluid includes skin-present contaminants and the second volume of bodily fluid is substantially free of skin-present contaminants.
4. The apparatus of claim 1 , wherein the pre-sample reservoir is defined at least in part by a portion of the flow diverter mechanism.
5. The apparatus of claim 1 , wherein the volume indicator is a visual indicator.
6. The device of claim 1 , wherein the flow diverter mechanism comprises a movable member configured to move through the second outlet port to place the sample reservoir in fluid communication with the second fluid flow path.
7. The apparatus of claim 6 , wherein the flow metering mechanism is at least partially disposed within a portion of the movable member.
8. 2. The device of claim 1, wherein the flow diverter mechanism is configured to fluidly isolate the pre-sample reservoir and at least a portion of the first fluid flow path when the first volume of blood is disposed in the pre-sample reservoir.
9. 2. The device of claim 1, wherein the flow diversion mechanism includes a third outlet port configured to fluidly couple a second sample reservoir to the flow diversion mechanism, defining a third fluid flow path configured to place the third outlet port in fluid communication with the inlet port.
10. 10. The device of claim 1, further comprising a flow controller defining a first lumen and a second lumen configured to move between a first configuration in which the first lumen places the first fluid flow path in fluid communication with the inlet port and a second configuration in which the second lumen places the second fluid flow path in fluid communication with the inlet port.
11. The device of claim 10 , wherein the flow controller is configured to move from the first configuration to the second configuration after the first volume of the bodily fluid is disposed in the pre-sample reservoir.
12. 1. An apparatus for obtaining a bodily fluid sample from a patient, comprising: a pre-sample reservoir configured to receive a first volume of bodily fluid drawn from the patient; a flow diversion mechanism including an inlet port, a first outlet port, and a second outlet port, the inlet port configured to be coupled to a lumen-defining device to receive bodily fluid from a patient, the first outlet port configured to fluidly couple the pre-sample reservoir to the flow diversion mechanism, and the second outlet port configured to fluidly couple a sample reservoir to the flow diversion mechanism; a flow controller disposed at least partially within the flow dividing mechanism, the flow controller configured to move between a first configuration in which the flow controller defines at least a portion of a fluid flow path between the inlet port and the first outlet port, and a second configuration in which the flow controller defines at least a portion of a fluid flow path between the inlet port and the second outlet port; a movable member movably coupled to the flow diverter mechanism, the movable member configured to move between a first configuration in which the sample reservoir is fluidly isolated from the fluid flow path between the inlet port and the second outlet port and a second configuration in which the sample reservoir is fluidly connected to the fluid flow path between the inlet port and the second outlet port through the second outlet port, the sample reservoir configured to receive a second volume of bodily fluid drawn from the patient when the flow controller is in its second configuration and the movable member is in its second configuration.
13. 13. The device of claim 12, wherein the first volume of bodily fluid includes skin-present contaminants and the second volume of bodily fluid is substantially free of skin-present contaminants.
14. The apparatus of claim 12 , wherein the flow controller rotates between its first configuration and its second configuration relative to the flow diverter structure.
15. The apparatus of claim 12 , wherein the flow controller moves in a linear motion relative to the flow diverter mechanism.
16. The apparatus of claim 12 , wherein the flow controller is configured to fluidly isolate the pre-sample reservoir when in its second configuration.
17. The apparatus of claim 12 , wherein the movable member includes a piercing member configured to pierce a portion of the sample reservoir when the movable member is in its second configuration.
18. The apparatus of claim 12 , wherein the movable member is coupled to a biasing member configured to at least temporarily maintain the movable member in its first configuration.
19. The apparatus of claim 12 , wherein the flow diversion mechanism includes a third outlet port configured to fluidly couple a second sample reservoir to the flow diversion mechanism.
20. the movable member being a first movable member, the apparatus comprising:
20. The apparatus of claim 19, further comprising a second movable member configured to move through the third outlet port between a first configuration in which the second sample reservoir is fluidly isolated from a fluid flow path defined between the inlet port and the third outlet port and a second configuration in which the second sample reservoir is fluidly connected to the fluid flow path defined between the inlet port and the third outlet port, the second sample reservoir configured to receive a third volume of bodily fluid drawn from the patient when the flow controller is in its second configuration and the second movable member is in its second configuration.
21. 1. An apparatus for obtaining a bodily fluid sample from a patient, comprising: a pre-sample reservoir configured to receive a first volume of bodily fluid drawn from the patient; a flow diversion mechanism including a housing and a distribution member, the housing defining a first opening and a second opening, the first opening in fluid communication with the pre-sample reservoir, the distribution member at least partially disposed within the housing and defining a fluid flow path in fluid communication with the second opening, the distribution member including a coupling portion in fluid communication with the flow path and configured to be physically and fluidly coupled to a sample reservoir; 11. An apparatus comprising: a flow controller including an inlet port configured to be coupled to a lumen-defining device to receive bodily fluid from the patient, the flow controller being rotatably coupled to the flow diverter mechanism and configured to move between a first configuration in which the inlet port is in fluid communication with the first opening and a second configuration in which the inlet port is in fluid communication with the second opening.
22. 22. The device of claim 21, wherein the first volume of bodily fluid includes skin-present contaminants and the second volume of bodily fluid is substantially free of skin-present contaminants.
23. 22. The apparatus of claim 21, wherein the pre-sample reservoir is defined at least in part by a portion of the distribution member.
24. 22. The apparatus of claim 21, wherein the coupling portion comprises a piercing member configured to pierce a portion of the sample reservoir to place the sample reservoir in fluid communication with the fluid flow path.
25. 25. The device of claim 24, wherein the piercing of the portion of the sample reservoir by the piercing member initiates a flow of bodily fluid from the patient through the inlet port and the flow path into the sample reservoir when the flow controller is in its second configuration.
26. 22. The device of claim 21, wherein the first volume of bodily fluid is a first predetermined volume of bodily fluid, and the fluid flow path is configured to receive a second predetermined volume of bodily fluid, the second predetermined volume of bodily fluid relating to a sample volume.
27. 27. The apparatus of claim 26, wherein the sample volume is between about 10 milliliters and about 50 milliliters.
28. 27. The apparatus of claim 26, wherein the sample volume is about 30 milliliters.
29. 22. The apparatus of claim 21, wherein the flow diverter mechanism includes a seal member disposed between the housing and the flow controller such that when the flow controller is coupled to the flow diverter mechanism, the seal member forms a substantially fluid-tight seal with a surface of the flow controller and a surface of the housing, the seal member defining a first opening and a second opening, the first opening of the seal member being substantially coaxial with the first opening of the housing, and the second opening of the seal member being substantially coaxial with the second opening of the housing.
30. 1. A method of obtaining a predetermined sample volume of bodily fluid from a patient using a flow metering transfer device, the flow metering transfer device comprising: a flow diverter mechanism including an inlet port configured to be selectively placed in fluid communication with a pre-sample reservoir and a sample reservoir; and a flow metering mechanism configured to meter a flow of bodily fluid from the patient to the pre-sample reservoir and to the sample reservoir; establishing fluid communication between the patient and the port of the flow metering transfer device; establishing fluid communication between the port and the pre-sample reservoir; metering a flow of bodily fluid transferred from the patient to the pre-sample reservoir; verifying via the flow metering mechanism of the flow metering transfer device that a pre-sample volume of bodily fluid placed in the pre-sample reservoir is a predetermined pre-sample volume of bodily fluid; fluidly isolating the pre-sample reservoir from the port to seal a pre-sample volume of the bodily fluid within the pre-sample reservoir; establishing fluid communication between the port and the sample reservoir; metering a flow of bodily fluid transferred from the patient to the sample reservoir; and verifying that a sample volume of bodily fluid placed in the sample reservoir via the flow metering mechanism of the flow metering transfer device is a predetermined sample volume of bodily fluid.
31. 31. The method of claim 30, wherein the flow metering transfer device includes a flow controller configured to move between a first configuration in which fluid communication is established between the patient and the pre-sample reservoir and a second configuration in which fluid communication is established between the patient and the sample reservoir.
32. 31. The method of claim 30, wherein the bodily fluid is blood.
33. 33. The method of claim 32, wherein the sample reservoir comprises at least one of an aerobic medium or an anaerobic medium.
34. 31. The method of claim 30, wherein the predetermined pre-sample volume is between about 1 milliliter and about 10 milliliters.
35. 31. The method of claim 30, wherein the predetermined sample volume is between about 20 milliliters and about 60 milliliters.
36. 31. The method of claim 30, wherein the predetermined sample volume is about 60 milliliters.
37. the sample reservoir is a first sample reservoir and the sample volume is a first sample volume; establishing fluid communication between the port and a second sample reservoir after verifying that the first sample volume in the first sample reservoir is the predetermined sample volume; metering a flow of bodily fluid transferred from the patient to the second sample reservoir; 31. The method of claim 30, further comprising verifying that a second sample volume of bodily fluid placed in the second sample reservoir is the predetermined sample volume of bodily fluid via the flow metering mechanism of the flow metering transfer device.
38. 38. The method of claim 37, wherein the first sample volume and the second sample volume collectively equal between about 20 milliliters and about 60 milliliters.
39. establishing fluid communication between the port and a third sample reservoir after verifying that the second sample volume in the second sample reservoir is the predetermined sample volume; metering a flow of bodily fluid transferred from the patient to the third sample reservoir; 40. The method of claim 37, further comprising verifying via the flow metering mechanism of the flow metering transfer device that a third sample volume of bodily fluid placed in the third sample reservoir is the predetermined sample volume of bodily fluid.
40. 40. The method of claim 39, wherein the first sample volume, the second sample volume, and the third sample volume collectively equal between about 30 milliliters and about 60 milliliters.
41. 40. The method of claim 39, wherein the first sample volume, the second sample volume, and the third sample volume collectively equal about 60 milliliters.
Citation Information
Patent Citations
Disposable flexible connection hirudin anti-coagulation transverse vacuum blood collection kit
CN101785676A
JP1973046180A
Systems and methods for parenterally procuring bodily-fluid samples with reduced contamination
US20080145933A1
Clamp and blood collecting device
US20110288441A1
Device for withdrawing fluids
US5097842A
